{
  "meta": {
    "title": "00385_Late_Night_Pyq_Pyt_Medicine-1_1",
    "url": "https://brainandscalpel.vercel.app/00385-late-night-pyq-pyt-medicine-1-1-90d17bf8.html",
    "scrapedAt": "2025-11-29T17:29:36.118Z"
  },
  "questions": [
    {
      "id": 11698,
      "choices": [
        {
          "id": 46758,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tip of nose to ear to xiphisternum</span></span></span></span></p>"
        },
        {
          "id": 46759,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tip of nose to angle of ear to umbilicus </span></span></span></span></p>"
        },
        {
          "id": 46760,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mouth to ear to umbilicus</span></span></span></span></p>"
        },
        {
          "id": 46761,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mouth to ear to midway between xiphisternum and umbilicus</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">As an intern in emergency ward, which of the following method would you consider as correct regarding nasogastric tube length estimation? (AIIMS NOV 2018)</span></span></span></span></p>",
      "unique_key": "Q7695323",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365420,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Tip of nose to ear to xiphisternum (i.e., N-E-X)</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Approximate length of nasogastric tube is 120 -125cm&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">How to confirm correct position of NG tube: </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Auscultation in the epigastric area while injecting a bolus of air</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">x-ray chest</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Colorimetric capnography </span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/27/nm113.jpg\" style=\"height:713px; width:562px\" /></p>\r\n\r\n<p style=\"margin-left:240px\">&nbsp;</p>\r\n\r\n<p style=\"margin-left:240px\"><span style=\"font-size:9pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"color:#44546a\"><em><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"color:#0d0d0d\">XIPHISTERNUM</span></strong></em></span></span></span></p>\r\n\r\n<p style=\"margin-left:240px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\">Place the tip of the nasogastric tube at the tip of the nose, then measure from the nose to the ear lobe &amp; down to the tip of the Xiphisternum</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Tip of nose to angle of ear to umbilicus:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This measurement is too long as it typically extends beyond the stomach, potentially reaching into the intestines.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Mouth to ear to umbilicus:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This measurement is also incorrect and typically used for other medical estimations, not for NG tube placement.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Mouth to ear to midway between xiphisternum and umbilicus:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Similar to option B, this measurement is excessively long for proper NG tube placement.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">When inserting a nasogastric tube, the correct measurement to estimate the necessary tube length is from the tip of the nose to the earlobe to the xiphisternum, ensuring the tube reaches the stomach properly for effective therapeutic or diagnostic use.</span></span></span></span></p>",
      "correct_choice_id": 46758,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "InstrumentsBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11864,
      "choices": [
        {
          "id": 47422,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Antihistone antibodies</span></span></p>"
        },
        {
          "id": 47423,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anti-dsDNA antibodies</span></span></p>"
        },
        {
          "id": 47424,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anticentromere antibodies</span></span></p>"
        },
        {
          "id": 47425,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Antinuclear antibodies</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A young patient presents to the clinic with erythematous lesions over the exposed areas of the skin like hands, arms, chest, etc. She also complains of arthralgia and breathlessness. Which among the following antibodies will be useful in diagnosing this condition? (INICET NOV 2022)</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/13/whatsapp-image-2024-09-13-at-103830-am.jpeg\" style=\"height:257px; width:300px\" /></p>",
      "unique_key": "Q8595702",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365434,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Anti-dsDNA antibodies</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient exhibits symptoms including erythematous lesions on sun-exposed areas of the skin, arthralgia, and breathlessness, which are characteristic of Systemic Lupus Erythematosus (SLE). The rash described is typical of an SLE rash and not dermatomyositis, which presents with rashes over the knuckles known as Gottron&#39;s papules.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">For diagnosing SLE, anti-dsDNA antibodies are very useful due to their high specificity. Although their sensitivity is relatively low (30-50%), the specificity is very high (&gt;90-95%), making them reliable markers for confirming the diagnosis of SLE. Anti-dsDNA antibodies are also associated with disease activity in SLE.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Antihistone antibodies:</span></strong><span style=\"font-size:12.0pt\"> These are primarily associated with drug-induced lupus erythematosus, not classic SLE.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Anticentromere antibodies:</span></strong><span style=\"font-size:12.0pt\"> These are typically seen in limited forms of scleroderma, particularly CREST syndrome, and are not associated with SLE.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Antinuclear antibodies (ANA):</span></strong><span style=\"font-size:12.0pt\"> While ANA is a good initial screening test for SLE due to its high sensitivity, it lacks specificity. ANA can be positive in a variety of autoimmune conditions, thus it is not as specific as anti-dsDNA antibodies for diagnosing SLE.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Anti-dsDNA antibodies are highly specific for diagnosing Systemic Lupus Erythematosus (SLE), despite their moderate sensitivity.</span></span></span></p>",
      "correct_choice_id": 47423,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11740,
      "choices": [
        {
          "id": 46926,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chronic respiratory acidosis, acute metabolic alkalosis</span></span></span></span></p>"
        },
        {
          "id": 46927,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute respiratory acidosis, acute respiratory alkalosis</span></span></span></span></p>"
        },
        {
          "id": 46928,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute Metabolic alkalosis, acute respiratory acidosis</span></span></span></span></p>"
        },
        {
          "id": 46929,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute respiratory acidosis, acute metabolic alkalosis</span></span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identify the areas marked F, C in the following diagram: (INICET NOV 2020)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/27/nm124.jpg\" style=\"height:306px; width:300px\" /></span></span></span></span></p>",
      "unique_key": "Q1505377",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365437,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B)&nbsp;</span></span></strong><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute respiratory acidosis, acute respiratory alkalosis</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Area F</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Positioned in the lower left part of the diagram, which corresponds to higher PCO2 and a pH less than 7.35. This area represents <strong>Acute Respiratory Acidosis</strong> due to an increase in CO2, causing a drop in blood pH.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Area C</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Positioned in the upper right part of the diagram, which corresponds to lower PCO2 and a pH greater than 7.45. This area represents <strong>Acute Respiratory Alkalosis</strong> caused by a decrease in CO2, increasing blood pH.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/27/nm125.jpg\" style=\"height:507px; width:496px\" /></span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Understanding the relationship between pH, bicarbonate (HCO3-), and CO2 is crucial for interpreting arterial blood gases. Area F indicates acute respiratory acidosis due to increased CO2, and area C indicates acute respiratory alkalosis due to decreased CO2.</span></span></span></span></p>",
      "correct_choice_id": 46927,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 65801,
      "choices": [
        {
          "id": 262365,
          "text": "<p><span style=\"font-size:12.0pt;\">Contralateral ataxia</span></p>"
        },
        {
          "id": 262366,
          "text": "<p><span style=\"font-size:12.0pt;\">Ipsilateral oculomotor nerve palsy</span></p>"
        },
        {
          "id": 262367,
          "text": "<p><span style=\"font-size:12.0pt;\">Contralateral hemiballismus</span></p>"
        },
        {
          "id": 262368,
          "text": "<p><span style=\"font-size:12.0pt;\">Contralateral hemiplegia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which among the following is WRONG regarding Claude's syndrome? <i>(Twisted PYQ)</i></span></p>",
      "unique_key": "Q4472855",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365397,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Contralateral hemiballismus</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p><br><span style=\"font-size:12.0pt;\"><strong>Claude's syndrome</strong> is a midbrain syndrome caused by lesions involving the red nucleus and oculomotor nerve. The key features include:</span></p><ul><li><span style=\"font-size:12.0pt;\"><strong>Ipsilateral oculomotor nerve palsy:</strong> Damage to cranial nerve III causes ptosis, pupillary dilation, and impaired eye movement.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Contralateral ataxia:</strong> Lesion of the red nucleus or dentato-rubro-thalamic tract leads to coordination deficits on the opposite side of the body.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A: Contralateral ataxia:</strong> Incorrect because contralateral ataxia is a hallmark feature of Claude's syndrome due to red nucleus involvement.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B: Ipsilateral oculomotor nerve palsy:</strong> Incorrect because Claude's syndrome commonly affects cranial nerve III, causing oculomotor palsy on the same side as the lesion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D: Contralateral hemiplegia:</strong> Incorrect because hemiplegia is associated with Weber’s syndrome, not Claude's syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Claude's syndrome is characterized by ipsilateral oculomotor nerve palsy and contralateral ataxia due to lesions in the midbrain affecting the red nucleus and associated tracts. Contralateral hemiballismus is not a feature of Claude's syndrome and is more commonly linked to subthalamic nucleus damage.</span></p>",
      "correct_choice_id": 262367,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47605,
      "choices": [
        {
          "id": 190031,
          "text": "<p><span style=\"font-size:12.0pt;\">Alteplase</span></p>"
        },
        {
          "id": 190032,
          "text": "<p><span style=\"font-size:12.0pt;\">Streptokinase</span></p>"
        },
        {
          "id": 190033,
          "text": "<p><span style=\"font-size:12.0pt;\">Primary Angioplasty</span></p>"
        },
        {
          "id": 190034,
          "text": "<p><span style=\"font-size:12.0pt;\">Dual Antiplatelet therapy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A young patient presents in a multi-specialty hospital with sudden onset chest pain since 1 hour with ECG showing ST elevation in leads II, III, and aVF. What is the best treatment?&nbsp;</span>(FMGE JANUARY 2024)</p>",
      "unique_key": "Q9531341",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365448,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Primary Angioplasty</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient presents with symptoms and ECG findings indicative of an acute inferior ST-elevation myocardial infarction (STEMI). The presence of ST elevation in leads II, III, and aVF confirms the diagnosis. Primary percutaneous coronary intervention (PCI), also known as primary angioplasty, is the best treatment for STEMI if it can be performed promptly. PCI is preferred because it directly opens the blocked coronary artery, restoring blood flow more quickly and effectively than thrombolytic therapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Note - If Primary PCI not possible or delayed due to some reasons then thrombolytic therapy (dual antiplatelet therapy) is used.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Alteplase:&nbsp;</strong>This is a thrombolytic agent used to dissolve clots but is considered when PCI is not available or will be delayed.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Streptokinase:&nbsp;</strong>Another thrombolytic agent, similar to alteplase, used when PCI is not an option.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Dual Antiplatelet therapy:&nbsp;</strong>This is an essential part of the initial management of STEMI, involving a combination of aspirin and a P2Y12 receptor inhibitor (like clopidogrel, ticagrelor, or prasugrel). However, it is not the definitive treatment compared to PCI.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Primary angioplasty (PCI) is the best treatment for patients presenting with STEMI, especially when it can be performed within the recommended time frame, as it effectively restores blood flow to the affected myocardium. ​</span></p>",
      "correct_choice_id": 190033,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11737,
      "choices": [
        {
          "id": 46914,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bilirubin</span></span></span></span></p>"
        },
        {
          "id": 46915,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Albumin</span></span></span></span></p>"
        },
        {
          "id": 46916,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prothrombin time</span></span></span></span></p>"
        },
        {
          "id": 46917,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Creatinine</span></span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Components of the MELD (2016) score are all except? (INICET NOV 2020)</span></span></p>",
      "unique_key": "Q1192876",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365435,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B)&nbsp;</span></span></strong><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Albumin</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The Model for End-Stage Liver Disease (MELD) score is used to prioritize patients for liver transplantation and assesses the severity of chronic liver disease. The MELD score includes three laboratory values:</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&ldquo;CBI mnemonic = Creatinine, Bilirubin, INR are the parameters is MELD score.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Currently Sodium levels to the score and MELD-Na score used for prognostication. Hyponatremia associated with adverse outcomes.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A.</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;<strong>Bilirubin:</strong> Reflects the liver&#39;s ability to excrete bilirubin.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong>INR (International Normalized Ratio) for prothrombin time:</strong> Indicates the liver&#39;s ability to synthesize clotting factors.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Creatinine:</strong> Assesses renal function, which can be compromised in liver failure. Additionally, sodium was added to the MELD score to improve its prognostic accuracy, resulting in the MELD-Na score.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Albumin is not a component of the MELD score. The key components are bilirubin, creatinine, and INR, with sodium also included in the updated MELD-Na scoring system to better predict outcomes in patients with end-stage liver disease.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reference: Harrison 21/Cirrhosis/Chap 344</span></span></strong></span></span></p>",
      "correct_choice_id": 46915,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11301,
      "choices": [
        {
          "id": 45170,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Medication overuse headache</span></span></p>"
        },
        {
          "id": 45171,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tension headache</span></span></p>"
        },
        {
          "id": 45172,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chronic migraine</span></span></p>"
        },
        {
          "id": 45173,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cluster headache</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 37-year-old woman presents with headaches for 6 months. She has been taking analgesics regularly. The headache recently increased in severity for 3 days but was reduced on stopping the analgesic. What is the likely diagnosis?</span> <span style=\"font-size:12.0pt\">(NEET PG 2021)</span></span></span></p>",
      "unique_key": "Q3606385",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365410,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A. Medication overuse headache</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Medication overuse headache (MOH) occurs in individuals who frequently use headache medications. The patient in this case has been experiencing headaches for six months and has been regularly using analgesics. The key indicator of MOH is the worsening of headaches with continued use of medication and improvement upon stopping the medication. This aligns with the patient&#39;s experience of increased headache severity for three days, which reduced once the analgesics were stopped.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">MOH develops as a result of the brain becoming sensitized to the medication, leading to a rebound effect. This is a well-recognized phenomenon where the headache itself is caused by the frequent use of headache relief medication, leading to a cycle of medication use and headache.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Tension headache:</span></strong><span style=\"font-size:12.0pt\"> Tension headaches are typically relieved by analgesics, not worsened. These headaches are often characterized by a feeling of a tight band around the head and can be managed effectively with over-the-counter pain relief medications.&nbsp; </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Acute Treatment</span></strong><span style=\"font-size:12.0pt\">: Nonsteroidal anti-inflammatory drugs (NSAIDs) or paracetamol are used to relieve pain.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Chronic Treatment</span></strong><span style=\"font-size:12.0pt\">: Tricyclic antidepressants, such as amitriptyline, are employed to manage chronic symptoms and reduce the recurrence of headaches.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Chronic migraine:</span></strong><span style=\"font-size:12.0pt\"> Chronic migraines are managed with both acute treatments for individual attacks and preventive treatments to reduce the frequency and severity of the headaches. While chronic migraines can be debilitating, they generally improve with proper prophylaxis and do not worsen with the use of analgesics. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Treatment options include propranolol, topiramate, valproate, and monoclonal antibodies against CGRP (calcitonin gene-related peptide), such as erenumab. These are used to reduce the frequency and severity of migraine attacks.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Cluster headache:</span></strong><span style=\"font-size:12.0pt\"> Cluster headaches are severe, unilateral headaches that are treated with high-flow oxygen and subcutaneous sumatriptan during acute attacks. Preventive treatments include medications like verapamil. Analgesics are not typically the first-line treatment for cluster headaches and their use does not generally lead to worsening of the condition.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Acute Treatment</span></strong><span style=\"font-size:12.0pt\">: High-flow 100% oxygen inhalation or subcutaneous sumatriptan injections are recommended to alleviate the intense pain of acute cluster headache attacks.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Chronic Treatment</span></strong><span style=\"font-size:12.0pt\">: Verapamil is used for long-term management to prevent the frequency and intensity of cluster headache episodes.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Medication overuse headache is characterized by the worsening of headaches due to frequent use of headache medications, and improvement upon cessation of the medication. This phenomenon highlights the importance of managing headache disorders with appropriate treatments and avoiding overuse of analgesics.</span></span></span></p>",
      "correct_choice_id": 45170,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11872,
      "choices": [
        {
          "id": 47454,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Putamen</span></span></p>"
        },
        {
          "id": 47455,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Subthalamic nucleus</span></span></p>"
        },
        {
          "id": 47456,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Caudate nucleus</span></span></p>"
        },
        {
          "id": 47457,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Globus pallidus</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A patient presented with violent, flinging movements. Where is the lesion causing the hemiballismus seen? (INICET NOV 2022)</span></span></span></p>",
      "unique_key": "Q3909935",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365438,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Subthalamic nucleus</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hemiballismus is characterized by involuntary, violent, flinging movements, typically on one side of the body. This condition is most commonly associated with a lesion in the subthalamic nucleus. The subthalamic nucleus plays a crucial role in regulating movements, and damage to this area can lead to the excessive, uncontrolled movements seen in hemiballismus. This differentiates it from lesions in other parts of the basal ganglia, which are associated with different movement disorders.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Putamen:</span></strong><span style=\"font-size:12.0pt\"> Lesions in the putamen are more commonly associated with chorea, which involves rapid, involuntary, and irregular movements, rather than the violent flinging movements of hemiballismus.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Caudate nucleus:</span></strong><span style=\"font-size:12.0pt\"> Similar to the putamen, lesions in the caudate nucleus typically result in chorea. The caudate nucleus is part of the striatum, and its dysfunction does not usually present with the violent movements characteristic of hemiballismus.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Globus pallidus:</span></strong><span style=\"font-size:12.0pt\"> Lesions in the globus pallidus often result in athetosis, which involves slow, writhing movements. This is different from the abrupt and forceful movements seen in hemiballismus.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hemiballismus, characterized by violent, flinging movements, is most commonly caused by a lesion in the subthalamic nucleus.</span></span></span></p>",
      "correct_choice_id": 47455,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11202,
      "choices": [
        {
          "id": 44774,
          "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&gt; 50 ug/L</span></span></p>"
        },
        {
          "id": 44775,
          "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&gt; 100 ug/L</span></span></p>"
        },
        {
          "id": 44776,
          "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&gt; 150 ug/L</span></span></p>"
        },
        {
          "id": 44777,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&gt; 200 ug/L</span></span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What levels of prolactin are definitely suggestive of prolactinoma? (NEET PG 2018)</span></span></p>",
      "unique_key": "Q3927676",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365428,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. &gt; 200 ug/L</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prolactin levels greater than 200 ug/L are definitely suggestive of a prolactinoma. This level typically indicates the presence of a prolactin-secreting pituitary adenoma. The significant elevation in prolactin can cause clinical symptoms such as galactorrhea and amenorrhea in women, or hypogonadism in men. The diagnosis is further supported by imaging studies such as MRI, which can visualize the adenoma.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Additional Information</span></span></strong></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/22/screenshot-2024-07-22-163238.jpg\" style=\"height:484px; width:1000px\" /></span></span></strong></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/22/screenshot-2024-07-22-163300.jpg\" style=\"height:402px; width:1000px\" /></p>",
      "correct_choice_id": 44777,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55348,
      "choices": [
        {
          "id": 220853,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">IV Labetalol</span></span></p>"
        },
        {
          "id": 220854,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">IV Nitroglycerin</span></span></p>"
        },
        {
          "id": 220855,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Oral Nifedipine</span></span></p>"
        },
        {
          "id": 220856,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">IV Hydralazine</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A 50-year-old male patient presents with headache and seizures. On examination his BP is 220/110 mm Hg. What is the most appropriate treatment? (FMGE JULY 2024)</span></span></p>",
      "unique_key": "Q5444878",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365419,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. A) IV Labetalol</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">In this case, the patient is experiencing a <strong>neurological hypertensive emergency</strong>, as indicated by his headache and seizures alongside a high blood pressure reading of 220/110 mm Hg. This condition could stem from several serious issues, including ischemic stroke, intracranial hemorrhage, or hypertensive encephalopathy.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The primary objective in managing a neurological hypertensive emergency is to safely reduce the blood pressure. For such emergencies, <strong>the first-line treatments typically include IV Nicardipine or IV Labetalol.</strong> Given that IV nicardipine is often not available in many Indian hospitals, IV labetalol becomes the preferred option, making it the <strong>Ans.</strong> in this scenario.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. IV Nitroglycerin:</strong> Nitrates, such as nitroglycerin, are generally avoided in neurological emergencies because they cause vasodilation, which can increase cerebral blood flow. This increase in blood flow can elevate intracranial pressure, potentially worsening the patient&#39;s condition.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Oral Nifedipine:</strong> Oral medications are not suitable for emergency situations due to their delayed onset of action. Immediate reduction of blood pressure is crucial in this case, making oral nifedipine inappropriate.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. IV Hydralazine:</strong> Although IV hydralazine is an arterial vasodilator, it is not recommended for neurological hypertensive emergencies. Similar to nitrates, it can lead to an increase in intracranial pressure and potentially exacerbate the patient&#39;s symptoms.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">In neurological hypertensive emergencies, the first-line treatment options for reducing blood pressure are IV nicardipine or IV labetalol, with IV labetalol being preferred if IV nicardipine is unavailable.</span></span></p>",
      "correct_choice_id": 220853,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55347,
      "choices": [
        {
          "id": 220849,
          "text": "<p><span style=\"font-size:12pt;\">Troponin</span></p>"
        },
        {
          "id": 220850,
          "text": "<p><span style=\"font-size:12pt;\">Ischemia modified albumin</span></p>"
        },
        {
          "id": 220851,
          "text": "<p><span style=\"font-size:12pt;\">LDH</span></p>"
        },
        {
          "id": 220852,
          "text": "<p><span style=\"font-size:12pt;\">CK MB</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Which of the following is earliest to rise in myocardial infarction? (FMGE JULY 2024)</span></p>",
      "unique_key": "Q5319851",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365418,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Ischemia modified albumin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In the event of a myocardial infarction, certain biomarkers are released into the bloodstream as a result of cardiac muscle injury.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Among the <strong>three early markers of myocardial injury</strong>, three are particularly significant: <strong>myoglobin, heart-type fatty acid binding protein (HFABP), and ischemia modified albumin (IMA).</strong> Of these three, ischemia modified albumin is the earliest to rise and also the earliest to fall in response to myocardial ischemia. This rapid change makes it a valuable early diagnostic marker for detecting myocardial infarction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Troponin:</strong> Troponins are highly specific markers for myocardial injury and are considered the gold standard for diagnosing myocardial infarction. However, they do not rise as early as ischemia modified albumin. Typically, troponin levels start to rise 4-6 hours after the onset of myocardial infarction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. LDH (Lactate Dehydrogenase):</strong> LDH is an enzyme found in almost all body tissues and is not specific to cardiac tissue. It is a later marker of myocardial infarction, usually rising within 24-48 hours after the onset of symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. CK MB (Creatine Kinase-MB):</strong> CK-MB is a specific isoenzyme found in heart muscle and is used as a marker for myocardial infarction. However, it does not rise as early as ischemia modified albumin. CK-MB levels typically start to increase 3-6 hours after myocardial infarction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Ischemia modified albumin is the earliest biomarker to rise in the event of a myocardial infarction, making it a crucial early indicator for diagnosis.</span></p>",
      "correct_choice_id": 220850,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54258,
      "choices": [
        {
          "id": 216501,
          "text": "<p><span style=\"font-size:12.0pt;\">Pulsus Paradoxus is usually seen</span></p>"
        },
        {
          "id": 216502,
          "text": "<p><span style=\"font-size:12.0pt;\">Pericardiocentesis may be required</span></p>"
        },
        {
          "id": 216503,
          "text": "<p><span style=\"font-size:12.0pt;\">Loud S1 is a common finding</span></p>"
        },
        {
          "id": 216504,
          "text": "<p><span style=\"font-size:12.0pt;\">Echo will show diastolic RA/RV collapse</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old female with a history of chest pain and upper respiratory tract infection, seven days ago, presents with shortness of breath. She has BP of 100/60 mm Hg and a pulse rate of 110/min. Chest x-ray reviews an enlarged heart, which appears like a water bottle. Which of the following is incorrect?</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q5137273",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365445,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong> <strong>C) Loud S1 is a common finding</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient is likely suffering from <strong>pericardial effusion</strong>, possibly progressing to cardiac tamponade, secondary to a recent viral infection. This is suggested by the history of an upper respiratory tract infection, the physical findings, and the characteristic \"water bottle\" appearance of the heart on the chest x-ray.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The incorrect statement is <strong>Loud S1 is a common finding</strong>. In fact, one of the hallmarks of cardiac tamponade is <strong>muffled or distant heart sounds</strong> due to the insulating effect of the pericardial fluid, as described in Beck's triad, which includes hypotension, jugular venous distension, and muffled heart sounds.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Pulsus Paradoxus is usually seen:</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">This is true. Pulsus paradoxus is a significant drop in blood pressure during inspiration, common in cardiac tamponade.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Pericardiocentesis may be required:</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">This is true. Pericardiocentesis is often necessary to remove the excess fluid and relieve pressure on the heart, especially if the patient is hemodynamically unstable.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Echo will show diastolic RA/RV collapse:</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">This is true. In cardiac tamponade, the pressure from the pericardial fluid prevents the right atrium and right ventricle from expanding during diastole, leading to their collapse.</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">Echocardiography will reveal this diastolic collapse, confirming cardiac tamponade.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In cardiac tamponade, muffled heart sounds are a key finding, not a loud S1.</span></p>",
      "correct_choice_id": 216503,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11738,
      "choices": [
        {
          "id": 46918,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carbimazole</span></span></span></span></p>"
        },
        {
          "id": 46919,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Methylthiouracil</span></span></span></span></p>"
        },
        {
          "id": 46920,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Levothyroxine</span></span></span></span></p>"
        },
        {
          "id": 46921,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hydrouracil</span></span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A woman with Grave&#39;s disease was taking antithyroid medication throughout her pregnancy. The baby was born with aplasia cutis congenita. Which drug could have caused this condition? (INICET NOV 2020)</span></span></p>",
      "unique_key": "Q2125201",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365436,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A)&nbsp;</span></span></strong><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carbimazole</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carbimazole is a medication used to treat hyperthyroidism and is known to cause teratogenic effects if used during pregnancy. It can lead to a rare congenital condition called aplasia cutis congenita, where the baby is born with localized areas of missing skin. The use of carbimazole, especially during the first trimester of pregnancy, is linked with this embryopathy, which highlights the importance of careful medication selection in pregnant women with thyroid disorders.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Methylthiouracil:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Although it is an antithyroid drug, it is less commonly used and not specifically associated with aplasia cutis congenita.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Levothyroxine:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is a thyroid hormone replacement and is used to treat hypothyroidism, not associated with congenital defects.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Hydrouracil:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This option appears to be a distractor as no such common drug name exists that is relevant in this context.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MMZ, Carbimazole associated with embryonopathy in first trimester</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Graves in Pregnancy:</span></span></span></span></p>\r\n\r\n<p style=\"margin-left:48px\">&nbsp;</p>\r\n\r\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&lt;16 weeks: PTU (MM teratogenic)</span></span></span></span></p>\r\n\r\n<p style=\"margin-left:48px\">&nbsp;</p>\r\n\r\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&gt;16 weeks: MMI (PTU hepatotoxicity)</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lactation: MMI (RAIA avoided 4-6 weeks after cessation of breastfeeding as RAI is concentrated in breast tissue)</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reference - Harrison 21/Hyperthyroidism/Graves/Chap 384</span></span></strong></span></span></p>",
      "correct_choice_id": 46918,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11264,
      "choices": [
        {
          "id": 45022,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyperthyroidism due to disease in the pituitary</span></p>"
        },
        {
          "id": 45023,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypothyroidism due to disease in the pituitary</span></p>"
        },
        {
          "id": 45024,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypothyroidism due to disease in the hypothalamus</span></p>"
        },
        {
          "id": 45025,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyperthyroidism due to disease in the hypothalamus</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A patient came to the hospital with complaints of lethargy, increased sleep, and weight gain. Investigations revealed low plasma TSH concentration. However, on the administration of TRH, the TSH levels increased. Which of the following conditions is likely in this patient?</span> <span style=\"font-size:12.0pt;\">(NEET PG 2020)</span></p>",
      "unique_key": "Q5604677",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365391,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Hypothyroidism due to disease in the hypothalamus</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Clinical history is suggestive of hypothyroidism. Presence of low TSH with suspected hypothyroidism indicates loss of Log relationship of TSH &amp; fT4 indicating a central cause. Administration of TRH improving TSH level indicates TRH deficiency which is mainly produced from the hypothalamus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A.&nbsp;</strong> <strong>Hyperthyroidism due to pituitary</strong>: &nbsp;Cause like TSHoma is very rare. Also, symptoms of thyrotoxicosis are not present in the patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. In pituitary disease: </strong>TSH will not improve with TRH administration as the gland is defective and cannot produce TSH.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. </strong>Thyrotoxicosis symptoms are not present in this patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">When evaluating a patient with hypothyroid symptoms and low TSH that responds to TRH administration, consider hypothalamic dysfunction as a probable cause. This is indicative of secondary hypothyroidism due to a lack of TRH production, affecting the pituitary’s secretion of TSH in the absence of exogenous stimulation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison/Hypothyroidism/Chap 383</strong></span></p>",
      "correct_choice_id": 45024,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47604,
      "choices": [
        {
          "id": 190027,
          "text": "<p><span style=\"font-size:12.0pt;\">Absent a wave</span></p>"
        },
        {
          "id": 190028,
          "text": "<p><span style=\"font-size:12.0pt;\">Absent y descent</span></p>"
        },
        {
          "id": 190029,
          "text": "<p><span style=\"font-size:12.0pt;\">Prominent y descent</span></p>"
        },
        {
          "id": 190030,
          "text": "<p><span style=\"font-size:12.0pt;\">Absent x descent</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient has muffled heart sounds with low BP and elevated JVP. What is the likely JVP finding?&nbsp;</span>(FMGE JANUARY 2024)</p>",
      "unique_key": "Q7698699",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365447,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Absent y descent</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The clinical presentation of muffled heart sounds, low blood pressure, and elevated jugular venous pressure (JVP) suggests cardiac tamponade. In cardiac tamponade, the JVP is elevated, and the typical waveform finding is a prominent x descent with a blunted or diminished y descent. This pattern is due to the restricted filling of the right atrium and ventricle during diastole because of the pressure exerted by the pericardial fluid.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Absent a wave:&nbsp;</strong>This is seen in patients with atrial fibrillation, where there is no organized atrial contraction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Prominent y descent:&nbsp;</strong>This is seen in patients with constrictive pericarditis, where there is a rapid early diastolic filling, known as Friedrich's sign.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Absent x descent:&nbsp;</strong>This is a feature of tricuspid regurgitation, where the backward flow of blood during systole reduces the x descent.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In cardiac tamponade, the JVP waveform shows a prominent x descent with an absent or blunted y descent. This is due to the restricted filling of the right heart chambers caused by the pericardial fluid, leading to characteristic clinical signs such as muffled heart sounds, hypotension, and elevated JVP</span></p>",
      "correct_choice_id": 190028,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11711,
      "choices": [
        {
          "id": 46810,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Repeat Inj. adenosine 6 mg</span></span></span></span></p>"
        },
        {
          "id": 46811,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Synchronized cardioversion</span></span></span></span></p>"
        },
        {
          "id": 46812,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inj. amiodarone 300 mg</span></span></span></span></p>"
        },
        {
          "id": 46813,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">DC cardioversion</span></span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The ECG of a patient who presented to the ER is as given below. The patient was already given a carotid massage and IV Adenosine but the BP is currently 60/30 mm Hg. What is the next best step of management? (AIIMS NOV 2019)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/27/nm97.jpg\" style=\"height:296px; width:700px\" /></span></span></span></span></p>",
      "unique_key": "Q1327024",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365425,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B)&nbsp;</span></span></strong><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Synchronized Cardioversion</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Any hemodynamically unstable rhythm, requires synchronized cardioversion (Shock delivered in sync with R wave to prevent R-on T phenomenon). </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Synchronized Cardioversion&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is the correct choice for a hemodynamically unstable patient, as it is intended to restore normal heart rhythm without causing further cardiac risks. Synchronization ensures that the shock is delivered at a safe point in the QRS complex to prevent the induction of ventricular fibrillation.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A.&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Maximum of 30mg of adenosine can be tried if patient is <em>Hemodynamically Stable</em></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C.&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amiodarone is used in the treatment of chronic arrhythmias and rarely for acute treatment of SVT</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D.</strong>&nbsp;</span></span><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">DC cardioversion&nbsp;</span></strong>technically refers to the same treatment as synchronized cardioversion in the context of unstable rhythms but the lack of specification about synchronization could imply a risk if not properly timed.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Synchronised cardioversion avoid possibility of R on T phenomenon.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/11/screenshot-2024-09-11-112319.png\" style=\"height:445px; width:1000px\" /></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/27/nm118.jpg\" style=\"height:364px; width:700px\" /></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In cases of hemodynamically unstable tachyarrhythmias where initial pharmacological interventions fail, synchronized cardioversion should be promptly employed to stabilize the patient. This technique is crucial for preventing progression to more severe complications such as cardiac arrest.</span></span></span></span></p>",
      "correct_choice_id": 46811,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ImageBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 45822,
      "choices": [
        {
          "id": 182915,
          "text": "<p><span style=\"font-size:12.0pt;\">Obesity</span></p>"
        },
        {
          "id": 182916,
          "text": "<p><span style=\"font-size:12.0pt;\">Urticaria</span></p>"
        },
        {
          "id": 182917,
          "text": "<p><span style=\"font-size:12.0pt;\">Nasal polyp</span></p>"
        },
        {
          "id": 182918,
          "text": "<p><span style=\"font-size:12.0pt;\">Rhinosinusitis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Samter’s triad refers to the association of Aspirin-sensitive asthma and: (NEET PG 2017)</span></p>",
      "unique_key": "Q3998969",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365450,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><strong>Ans. C) Nasal polyp</strong></p><p>&nbsp;</p><p><strong>Explanation:</strong></p><p>&nbsp;</p><p>Samter's triad (also called AERD - Aspirin Exacerbated Respiratory Disease) consists of nasal polyps, bronchial asthma, and aspirin hypersensitivity. This classic triad represents a specific phenotype of asthma that often presents with severe symptoms and can be challenging to manage due to the multiple body systems involved and the potential for severe reactions to NSAIDs.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option A. Obesity</strong>: While obesity can be associated with asthma and may contribute to its severity, it is not a component of Samter's triad. Obesity is a risk factor for OSA and can worsen asthma control, but it's not part of this specific syndrome.</p><p>&nbsp;</p><p><strong>Option B. Urticaria</strong>: Urticaria (hives) is not part of Samter's triad. While aspirin sensitivity can sometimes cause urticaria in some patients, it's not a defining feature of Samter's triad which specifically involves the respiratory tract.</p><p>&nbsp;</p><p><strong>Option D. Rhinosinusitis</strong>: While patients with Samter's triad frequently have chronic rhinosinusitis, the specific defining feature mentioned in the triad is nasal polyps, not rhinosinusitis itself. Nasal polyps represent a more specific pathological finding.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Samter's triad is the specific association of three clinical entities: nasal polyps, bronchial asthma, and aspirin hypersensitivity, representing a distinct clinical syndrome requiring specific management considerations.</span></p>",
      "correct_choice_id": 182917,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55346,
      "choices": [
        {
          "id": 220845,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Anterior MI</span></span></p>"
        },
        {
          "id": 220846,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Inferior MI</span></span></p>"
        },
        {
          "id": 220847,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Lateral MI</span></span></p>"
        },
        {
          "id": 220848,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Posterior MI</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A 40-year-old patient presents with chest pain and an ECG was taken. What will be the likely diagnosis? (FMGE JULY 2024)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/30/screenshot-2024-08-30-101033.png\" style=\"height:114px; width:300px\" /></span></span></p>",
      "unique_key": "Q2632483",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365417,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. A) Anterior MI</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The ECG shows ST elevations primarily in leads V1, V2, V3, and V4. These elevations are also seen to some extent in V5 and aVL, with reciprocal ST depressions in leads II, III, and aVF. These findings are characteristic of an anterior myocardial infarction (MI).</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options: </strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Inferior MI:</strong> This would present with <strong>ST elevations in leads II, III, and aVF</strong>. These changes are not observed in the provided ECG.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Lateral MI:</strong> This type of MI would show <strong>ST elevations primarily in leads I, aVL, and possibly V5 and V6</strong>, but not in leads V1 to V4.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Posterior MI:</strong> The diagnosis of a posterior MI is typically confirmed by obtaining posterior leads (<strong>V7, V8, and V9) to demonstrate ST elevations</strong>. Alternatively, it can be inferred from <strong>characteristic ST depressions in leads V1 and V2, often with a tall R wave and upright T wave</strong>, which are not seen in this case.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective: </strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Anterior MI is characterized by ST elevations in leads V1 to V4, with possible involvement of V5 and AVL, and reciprocal ST depressions in leads II, III, and aVF.</span></span></p>",
      "correct_choice_id": 220845,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "FMGE",
        "ImageBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11497,
      "choices": [
        {
          "id": 45954,
          "text": "<p><span style=\"font-size:12.0pt;\">Cerebral malaria</span></p>"
        },
        {
          "id": 45955,
          "text": "<p><span style=\"font-size:12.0pt;\">Leptospirosis</span></p>"
        },
        {
          "id": 45956,
          "text": "<p><span style=\"font-size:12.0pt;\">Brucellosis</span></p>"
        },
        {
          "id": 45957,
          "text": "<p><span style=\"font-size:12.0pt;\">Typhoid</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Following is a graphic representation of a patient admitted in medicine ward with fever. What could be the possible diagnosis? (AIIMS MAY 2020)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/picture33.jpg\" alt=\"\" width=\"300\" height=\"179\"></span></p>",
      "unique_key": "Q2289665",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365442,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B)&nbsp;Leptospirosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Image shows typical&nbsp;<strong>biphasic illness with initial leptospiremic</strong> <strong>phase&nbsp;</strong>followed by immune phase.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Other illness that shows biphasic pattern include measles, Tick borne encephalitis virus, rarely Zika virus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><i><strong>Modified Faine Criteria </strong></i><strong>is used for diagnosis.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/picture34.jpg\" alt=\"\" width=\"600\" height=\"386\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A.&nbsp;</strong>Monophasic illness with predominant CNS and multisystem involvement.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C</strong>. Undulant fever presenting with PUO, muscle pain, thoracic backpain</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D</strong>. Enteric fever causes step ladder pattern of fever.</span></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Leptospirosis should be considered in patients presenting with a biphasic fever pattern, especially when supported by epidemiologic data pointing to possible exposure to contaminated water or animals. Early diagnosis and treatment are crucial to prevent complications such as Weil's disease, which can lead to severe renal and hepatic issues.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison 21/Leptospirosis/Chap 184</strong></span></p>",
      "correct_choice_id": 45955,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11471,
      "choices": [
        {
          "id": 45850,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stop the treatment and follow up</span></span></span></span></p>"
        },
        {
          "id": 45851,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Continue treatment for another 2 years</span></span></span></span></p>"
        },
        {
          "id": 45852,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gradually taper the drug and stop treatment</span></span></span></span></p>"
        },
        {
          "id": 45853,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Continue lifelong treatment with antiepileptics</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 16-year-old who is taking antiepileptics, has had a seizure-free period of 6 months. She has no family history of epilepsy. Her EEG is now normal and she has a normal neurological exam and intelligence. What would be your advice? (AIIMS MAY 2019)</span></span></span></span></p>",
      "unique_key": "Q3903577",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365431,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Continue treatment for another 2 years </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In cases of epilepsy, particularly in children and adolescents, the continuation of antiepileptic drug (AED) therapy after a period of being seizure-free is typically recommended for about 2 years. This recommendation is based on the need to stabilize neurological function and minimize the risk of recurrence. The decision to discontinue AEDs should consider factors such as the duration of being seizure-free, EEG findings, the type of epilepsy, and the individual&rsquo;s neurological examination.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rationale for Continuing Treatment:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Continuing AED treatment for at least 2 years after achieving seizure control helps ensure the stability of the condition and reduces the likelihood of seizure recurrence, especially during the critical developmental years of adolescence.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Recurrences are most common in the first 3 months after discontinuing AEDs, making a cautious approach necessary.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Stop the treatment and follow up:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This would be risky given the short period of seizure freedom (only 6 months). Stopping treatment prematurely may lead to recurrence.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Gradually taper the drug and stop treatment:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is typically considered after a longer period of seizure freedom, usually a minimum of 2 years, not just 6 months.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Continue lifelong treatment with antiepileptics:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is generally reserved for cases of refractory epilepsy where seizures cannot be controlled with multiple medications, which does not seem to be the case here based on the information provided.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anti-epileptics once initiated <strong>must be continued for a minimum period of 2 years</strong>. Decision to stop AED is considered if, <strong>seizure free &gt; 2 years with normal MRI, EEG, seizure</strong> <strong>type</strong>.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Recurrences occur in the first 3 months of discontinuing AED.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reference - Harrison principles of internal Medicine 21st edition Pg. 12076</span></span></strong></span></span></p>",
      "correct_choice_id": 45851,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11348,
      "choices": [
        {
          "id": 45358,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">CD4+ T cell count</span></span></span></p>"
        },
        {
          "id": 45359,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Viral load</span></span></span></p>"
        },
        {
          "id": 45360,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">p24 antigen</span></span></span></p>"
        },
        {
          "id": 45361,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Viral serotype</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A patient with retro-positive status was started on 2nd line highly active antiretroviral therapy (HAART). Which of the following can be used to monitor treatment efficacy? (Neet pg 2022)</span></span></span></p>",
      "unique_key": "Q8938833",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365433,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">B. Viral load</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Viral load measurement is the primary method used to monitor the efficacy of antiretroviral therapy (ART) in patients with HIV. According to WHO and NACO guidelines, the monitoring of viral load is crucial for assessing the effectiveness of the treatment. Initially, viral load is <strong>monitored every six months until the regimen is stabilized</strong>. <strong>After that, it is monitored annually.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The goal of ART is to achieve an undetectable viral load, defined as <strong>less than 50 copies per mL</strong>. If the viral load is less than 50 copies, it indicates effective suppression of the virus, and the patient can continue with the same ART regimen with yearly monitoring. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">If the viral load exceeds 1000 copies, it suggests treatment failure</span></strong><span style=\"font-size:12.0pt\">, necessitating a change in the ART regimen. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">For viral loads between 50 and 1000 copies, the issue is often due to poor adherence to therapy,&nbsp;</span></strong><span style=\"font-size:12.0pt\">and it is recommended to ensure adherence and frequently <strong>monitor viral load every three months</strong> until suppression is achieved.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><span style=\"font-size:12pt\"><strong>A.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>CD4+ T cell count</strong>: Previously, CD4+ T cell count was commonly used to monitor HIV treatment. However, current guidelines prioritize viral load over CD4 count for monitoring treatment efficacy. While CD4 count is still important for assessing the immune system&#39;s health, it is not the primary marker for treatment efficacy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><span style=\"font-size:12pt\"><strong>C.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>p24 antigen</strong>: The p24 antigen is a protein associated with HIV. It is used for early detection of HIV infection but is not suitable for monitoring long-term treatment efficacy. p24 levels do not provide reliable information on viral suppression or ART effectiveness.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><span style=\"font-size:12pt\"><strong>D.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Viral serotype</strong>: Viral serotyping involves identifying different strains of HIV but does not provide information on treatment efficacy. It is more relevant in epidemiological studies and vaccine development rather than in monitoring ongoing therapy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Viral load measurement is the most important and recommended method for monitoring the efficacy of antiretroviral therapy in HIV patients. The goal is to achieve an undetectable viral load (&lt;50 copies/mL).</span></span></span></p>",
      "correct_choice_id": 45359,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "InvestigationBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11790,
      "choices": [
        {
          "id": 47126,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bartter syndrome</span></span></p>"
        },
        {
          "id": 47127,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Liddle syndrome</span></span></p>"
        },
        {
          "id": 47128,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gitelman syndrome</span></span></p>"
        },
        {
          "id": 47129,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gordon syndrome</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Which of the following conditions is associated with hypokalemic metabolic alkalosis with hypertension? (INICET NOV 2021)</span></span></span></p>",
      "unique_key": "Q4585263",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365402,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Liddle syndrome</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Liddle syndrome is a genetic disorder characterized by the overactivation of the epithelial sodium channels (ENaC) in the principal cells of the kidneys. This overactivation is due to a gain-of-function mutation in the genes encoding these channels. The increased activity of ENaC leads to excessive reabsorption of sodium and water, causing hypertension. Concurrently, there is increased excretion of potassium and hydrogen ions, which results in hypokalemia and metabolic alkalosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This condition is often referred to as<strong> pseudo-hyperaldosteronism</strong> because it mimics the effects of aldosterone but without elevated aldosterone levels. The treatment of choice for Liddle syndrome is amiloride, which directly inhibits ENaC channels, unlike spironolactone, which is ineffective in this condition.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Bartter syndrome:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Bartter syndrome also presents with hypokalemia and metabolic alkalosis, but patients typically have normal blood pressure. It is a group of autosomal recessive disorders that affect the thick ascending limb of the loop of Henle, mimicking the effects of loop diuretics. Symptoms often present in childhood and may include polyuria, polydipsia, and growth delays. Additionally, patients might have nephrocalcinosis due to increase urinary calcium, recurrent urinary stones, and sometimes sensorineural deafness.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Gitelman syndrome:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Gitelman syndrome, like Bartter syndrome, involves hypokalemia and metabolic alkalosis with normal blood pressure. It affects the distal convoluted tubule of the kidney, similar to the action of thiazide diuretics. Patients usually present in adulthood with symptoms such as muscle weakness, cramps, and <strong>tetany due to hypomagnesemia</strong>, which is a significant feature distinguishing it from Bartter syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Gordon syndrome:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Gordon syndrome, or <strong>pseudohypoaldosteronism</strong> type II, is characterized by hypertension and <strong>hyperkalemia, along with metabolic acidosis,</strong> not alkalosis. It results from mutations leading to increased sodium chloride reabsorption in the distal convoluted tubule. Unlike Liddle syndrome, patients with Gordon syndrome exhibit hyperkalemia and acidosis due to chloride retention.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Liddle syndrome is characterized by hypokalemic metabolic alkalosis and hypertension due to the overactivation of epithelial sodium channels in the kidneys.</span></span></span></p>",
      "correct_choice_id": 47127,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11398,
      "choices": [
        {
          "id": 45558,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Fever persisting for more than 3 weeks</span></p>"
        },
        {
          "id": 45559,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Immunocompromised status should be ruled out</span></p>"
        },
        {
          "id": 45560,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Undiagnosed after one week of investigation</span></p>"
        },
        {
          "id": 45561,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Temperature more than 38.3° C</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"color:black;font-size:12.0pt;\">Definition of PUO includes all of the following except? (AIIMS MAY 2017)</span></p>",
      "unique_key": "Q3748341",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365395,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Undiagnosed after one week of investigation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The correct answer is C because the definition of Pyrexia of Unknown Origin (PUO) does not specify that the fever must remain undiagnosed for only one week. According to the established criteria for diagnosing PUO, the investigation can be longer and more thorough before labeling a fever as PUO. The criteria include a fever exceeding 38.3°C on at least two occasions, persisting for more than three weeks, and a diagnosis that remains uncertain after comprehensive history taking, physical examinations, and routine investigations.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Fever persisting for more than 3 weeks:</strong> This is incorrect&nbsp;because it is a part of the definition of PUO, where the fever must last for more than three weeks.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Immunocompromised status should be ruled out:</strong> This is incorrect&nbsp; as a choice because being non-immunocompromised is a criterion in the diagnosis of PUO, which means any immunocompromised status should indeed be ruled out.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Temperature more than 38.3°C:</strong> This is also incorrect as it is part of the criteria, where the temperature must be more than 38.3°C on multiple occasions to consider it as PUO.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Criteria for diagnosis of PUO:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\">Fever &gt; 38.3 degrees C (101° F) on 2 occasions.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Duration &gt; 3 weeks.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Not immunocompromised state.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Diagnosis not certain after history, physical examination and routine and obligatory investigations.</span></li></ul>",
      "correct_choice_id": 45560,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "CriteriaBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16163,
      "choices": [
        {
          "id": 64612,
          "text": "<p><span style=\"font-size:12.0pt;\">Heparin</span></p>"
        },
        {
          "id": 64613,
          "text": "<p><span style=\"font-size:12.0pt;\">Beta blocker</span></p>"
        },
        {
          "id": 64614,
          "text": "<p><span style=\"font-size:12.0pt;\">Amiodarone</span></p>"
        },
        {
          "id": 64615,
          "text": "<p><span style=\"font-size:12.0pt;\">DC shock</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 72-year-old man with a history of HTN, DM2, and DLP is brought to the ER because of reports of palpitations and dizziness. ECG is ordered and shown in the image. His temperature is 36.8°C, PR is 106/min, RR is 18/min, BP is 84/46 mm Hg, and SpO2 is 92% on room air. What is the next step? (FMGE JAN 2023)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/30/screenshot-2024-09-30-091830.png\" alt=\"\" width=\"300\" height=\"171\"></span></p>",
      "unique_key": "Q3226854",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365408,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>D) DC shock</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient presents with <strong>atrial fibrillation (AF)</strong> characterized by an <strong>irregularly irregular rhythm and absence of well-defined P waves</strong> on the ECG. His vital signs indicate hemodynamic instability, specifically a low systolic blood pressure of 84 mm Hg (&lt;90 mm HG).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Why DC Shock is Correct:</strong> DC shock (synchronized cardioversion) is indicated for patients with tachyarrhythmia who are hemodynamically unstable. Hemodynamic instability is evidenced by a systolic blood pressure below 90 mm Hg, which is a critical threshold indicating the need for immediate cardioversion to restore normal rhythm and improve cardiac output.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Steps for Decision Making:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\"><strong>Identify the Rhythm:</strong> The ECG shows atrial fibrillation.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Assess Stability:</strong> The patient's systolic blood pressure is 84 mm Hg, indicating instability.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Treatment Protocol:</strong> Immediate synchronized cardioversion (DC shock) is necessary for unstable tachyarrhythmias.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Note -&nbsp;</strong>The three contraindications for using synchronized DC cardioversion are:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\"><strong>Sinus tachycardia</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Multifocal atrial tachycardia</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Digitalis toxicity</strong></span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Heparin</strong>: Heparin is used for anticoagulation in AF to prevent thromboembolism. However, it does not address hemodynamic instability or the immediate need to correct the arrhythmia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Beta blocker</strong>: Beta blockers are used for rate control in stable AF. They are inappropriate for acute management in hemodynamically unstable patients because they can further lower blood pressure and worsen instability.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Amiodarone</strong>: Amiodarone is an antiarrhythmic that can be used to convert AF to sinus rhythm, but it is not the first-line treatment in an unstable patient. Immediate cardioversion is preferred in this scenario.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In cases of tachyarrhythmia with hemodynamic instability (e.g., systolic BP &lt; 90 mm Hg), immediate synchronized cardioversion (DC shock) is the treatment of choice.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Rule of thumb: \"If the patient is in shock, shock the patient.\"</span></p>",
      "correct_choice_id": 64615,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "FMGE",
        "ImageBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11579,
      "choices": [
        {
          "id": 46282,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Sulfasalazine </span></span></span></p>"
        },
        {
          "id": 46283,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hydroxychloroquine</span></span></span></p>"
        },
        {
          "id": 46284,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Methotrexate</span></span></span></p>"
        },
        {
          "id": 46285,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Azathioprine</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Which of the following is NOT a first-line drug for the management of a patient with rheumatoid arthritis?</span> (<span style=\"font-size:12.0pt\">INICET MAY 2022)</span></span></span></p>",
      "unique_key": "Q6309258",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365422,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Azathioprine</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The first-line drugs for the management of rheumatoid arthritis (RA) are typically Disease-Modifying Antirheumatic Drugs (DMARDs), which include sulfasalazine, hydroxychloroquine, and methotrexate. These drugs are considered core therapies and are often used together in what is known as &quot;triple therapy.&quot;</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Sulfasalazine</span></strong><span style=\"font-size:12.0pt\">, <strong>hydroxychloroquine</strong>, and <strong>methotrexate</strong> are highly effective and commonly used in the treatment of RA. They form the backbone of conventional synthetic DMARDs (csDMARDs).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Azathioprine</span></strong><span style=\"font-size:12.0pt\">, on the other hand, is not a first-line drug for RA management. While it is used in some autoimmune conditions, it is not as effective for RA as the other mentioned drugs. Its efficacy is lower, and it is not commonly included in the standard RA treatment regimens.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Sulfasalazine</strong>:<strong> </strong>This drug is a part of the core therapies for RA and is commonly used as a first-line treatment. It is known for its effectiveness and is often used in combination with other DMARDs.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Hydroxychloroquine</span></strong><span style=\"font-size:12.0pt\">:<strong> </strong>Another key first-line drug for RA, hydroxychloroquine is widely used due to its efficacy and relatively favorable safety profile. It is often part of the triple therapy regimen.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Methotrexate</strong>: Methotrexate is considered the cornerstone of RA treatment and is usually the first drug prescribed. It is highly effective and forms the basis of most RA treatment protocols.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Azathioprine is not a first-line drug for the management of rheumatoid arthritis; the primary first-line drugs are sulfasalazine, hydroxychloroquine, and methotrexate.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Note - </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Sulfasalazine&nbsp;</span></strong><span style=\"font-size:12.0pt\">and <strong>Hydroxychloroquine</strong> are considered safe for use during pregnancy and are preferred in the management of RA among pregnant patients.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Azathioprine</span></strong><span style=\"font-size:12.0pt\"> is also somewhat safe during pregnancy, but it is not as effective for RA, so it is less preferred compared to Sulfasalazine and Hydroxychloroquine.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Methotrexate&nbsp;</span></strong><span style=\"font-size:12.0pt\">and <strong>Leflunomide</strong> are not safe for use during pregnancy and should be avoided due to potential risks to the developing fetus.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Additional Information:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Rheumatoid arthritis management: Range of biological disease-modifying antirheumatic drugs (bDMARDs) and targeted synthetic disease-modifying antirheumatic drugs (tsDMARDs). </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/07/screenshot-2024-09-07-152511.png\" style=\"height:626px; width:1000px\" /></span></span></span></p>",
      "correct_choice_id": 46285,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47909,
      "choices": [
        {
          "id": 191231,
          "text": "<p><span style=\"font-size:12.0pt;\">Ca⁺⁺ infusion test</span></p>"
        },
        {
          "id": 191232,
          "text": "<p><span style=\"font-size:12.0pt;\">Secretin injection test</span></p>"
        },
        {
          "id": 191233,
          "text": "<p><span style=\"font-size:12.0pt;\">ACTH stimulation test</span></p>"
        },
        {
          "id": 191234,
          "text": "<p><span style=\"font-size:12.0pt;\">Steroid assay</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Best provocative test for diagnosis of gastrinoma is: (NEET PG 2014)</span></p>",
      "unique_key": "Q1390174",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365411,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Secretin injection test</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Gastrinomas, also known as Zollinger-Ellison Syndrome (ZES), are characterized by hypersecretion of gastrin by a non-beta cell tumor, leading to excessive gastric acid production and peptic ulceration. The secretin injection test is the most valuable provocative test in diagnosing ZES.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Why the Secretin Injection Test is the Best:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Secretin, when injected, induces a substantial increase in serum gastrin levels in patients with gastrinoma, making it the most sensitive and specific test for ZES.</span></li><li><span style=\"font-size:12.0pt;\">Secretin stimulation test is preferred due to its higher sensitivity and specificity compared to other provocative tests.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Gastrinomas; Zollinger Ellison Syndrome Review:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/07/screenshot-2024-06-07-152439.JPG\" alt=\"\" width=\"1000\" height=\"429\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Treatment of ZES:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Proton Pump Inhibitors (PPIs): Preferred treatment to control gastric acid secretion.</span></li><li><span style=\"font-size:12.0pt;\">Surgical Intervention: Considered in cases where PPIs are not effective or if there are complications.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The secretin injection test is the gold standard provocative test for diagnosing gastrinoma due to its high sensitivity and specificity.</span></p>",
      "correct_choice_id": 191232,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11201,
      "choices": [
        {
          "id": 44770,
          "text": "<p><span style=\"font-size:12.0pt;\">Nephrogenic DI</span></p>"
        },
        {
          "id": 44771,
          "text": "<p><span style=\"font-size:12.0pt;\">Primary polydipsia</span></p>"
        },
        {
          "id": 44772,
          "text": "<p><span style=\"font-size:12.0pt;\">Pituitary DI</span></p>"
        },
        {
          "id": 44773,
          "text": "<p><span style=\"font-size:12.0pt;\">Mannitol infusion</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A patient presents with frequent urination, nocturia, and enuresis. 24-hour urine volume was measured and recorded to be 7 liters. The urine osmolarity was 260 mOsm/L. ADH assay was performed and the recorded values were reported as 0.8 pg/mL. An MRI of the brain was performed and T1 weighted indicated the absence of the bright spot. What is the most likely diagnosis? (NEET PG 2018)</span></p>",
      "unique_key": "Q4752231",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365427,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Pituitary DI</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient's symptoms of frequent urination, nocturia, and enuresis combined with a large urine output (7 liters) and low urine osmolarity (260 mOsm/L) suggest a deficiency in ADH effect. The low ADH level (0.8 pg/mL) and the absence of the bright spot on T1 weighted MRI (indicative of a pituitary abnormality) further support the diagnosis of Pituitary Diabetes Insipidus (DI). In Pituitary DI, ADH (vasopressin) is not adequately produced by the hypothalamus or released from the posterior pituitary, which leads to reduced water reabsorption in the kidney and subsequent polyuria.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Approach to Polyuria:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Water vs solute diuresis:&nbsp;</strong>(first thing to know)</span></li><li><span style=\"font-size:12.0pt;\">Water diuresis: DI, Primary polydipsia</span></li><li><span style=\"font-size:12.0pt;\"><strong>Solute diuresis:</strong></span><ul><li><span style=\"font-size:12.0pt;\">Glycosuria (Hyperglycemia, SGLT2 inhibitor use)</span></li><li><span style=\"font-size:12.0pt;\">Iatrogenic hyper-osmolar agents (Hypertonic saline, Mannitol, Urea - from high-protein tube feeding, Radiocontrast agents)</span></li><li><span style=\"font-size:12.0pt;\">Salt wasting (e.g., Medullary cystic disease, Diuretics, CSWS, Obstructive uropathy -especially if B/L, resolving ATN)</span></li></ul></li><li><span style=\"font-size:12.0pt;\">Before giving desmopressin → S. Na+ should be 145(or) P. Osm should be &gt; 295.</span></li><li><span style=\"font-size:12.0pt;\">If this cannot be achieved (usually due to severe thirst) during water deprivation - Alternative for water deprivation is Hypertonic saline infusion to achieve S. Na &gt; 145 or P. Osm &gt; 295 - then desmopressin test can be performed.</span></li><li><span style=\"font-size:12.0pt;\">Hypertonic saline (to ↑P. Osm) + Plasma AVP measurement in response to ↑ P. Osm due to hypertonic saline. Plasma AVP is unstable and needs stringent storage techniques. Based on AVP levels- can diagnose pituitary vs nephrogenic vs primary polydipsia. Diagnostic accuracy is questionable.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:11pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/23/nm4.jpg\" alt=\"\" width=\"1000\" height=\"594\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>**Plasma Co-Peptin&nbsp;</strong>(analogues to C-peptide of insulin) can be used for central vs nephrogenic DI.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Nephrogenic DI:&nbsp;</strong>Incorrect because it typically involves normal or high levels of ADH, but the kidneys do not respond to it. The patient's ADH is low, making this diagnosis less likely.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Primary polydipsia:&nbsp;</strong>This is associated with excessive fluid intake leading to large volumes of dilute urine but generally will not affect ADH levels significantly, and the brain MRI would typically be normal.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Mannitol infusion:&nbsp;</strong>This causes an osmotic diuresis due to the mannitol not being reabsorbed in the renal tubules. There is no evidence of mannitol administration in the patient's history.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>MMS algorithm for finding out the cause</u></strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:11pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/17/untitled-403.jpg\" alt=\"\" width=\"1000\" height=\"426\"></span></p>",
      "correct_choice_id": 44772,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20249,
      "choices": [
        {
          "id": 80957,
          "text": "<p><span style=\"font-size:12.0pt;\">Thyroid receptor antibody</span></p>"
        },
        {
          "id": 80958,
          "text": "<p><span style=\"font-size:12.0pt;\">Radioactive Iodine Uptake</span></p>"
        },
        {
          "id": 80959,
          "text": "<p><span style=\"font-size:12.0pt;\">Ultrasensitive thyrotropin</span></p>"
        },
        {
          "id": 80960,
          "text": "<p><span style=\"font-size:12.0pt;\">Anti-thyroid peroxidase antibody</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 23-year-old medical student with a 2-month history of palpitations, sweating, and restlessness. He also complains of a sweaty palm. His appearance is as shown in the picture. What is the next step in evaluation? (NEET PG 2023)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/30/screenshot-2024-07-30-143515.jpg\" alt=\"\" width=\"300\" height=\"154\"></span></p>",
      "unique_key": "Q8785282",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365404,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Ultrasensitive thyrotropin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient's symptoms and the clinical image strongly suggest Graves' Orbitopathy (also known as Graves' Ophthalmopathy), characterized by proptosis, eyelid edema, and eye congestion. The most common cause of both unilateral and bilateral exophthalmos is Graves' disease, an autoimmune disorder leading to hyperthyroidism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The next step in evaluating a patient suspected of having hyperthyroidism is to perform a thyroid function test (TFT), with the most important initial test being the measurement of Thyroid Stimulating Hormone (TSH). The ultrasensitive thyrotropin test, which measures TSH levels, is crucial because it helps in determining the presence of hyperthyroidism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In Graves' disease, TSH levels are typically very low or undetectable, while <strong>free T4</strong> and Total T3 levels are elevated (primary hyperthyroidism).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">IOC – MRI of the orbit</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">TOC – mild – moderate disease – conservative management</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Mod.-severe disease – first line TOC – CS (Dexamethasone); </span><span style=\"background-color:white;color:#202124;font-size:12.0pt;\">Teprotumumab (IGF1 receptor inhibitor Mab)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Thyroid receptor antibody:</strong> This test is specific <strong>for confirming</strong> Graves' disease, but it is not the first step. It is used after initial thyroid function tests suggest hyperthyroidism to confirm the diagnosis. The antibodies known as TRAb (TSH receptor antibody/ Thyroid receptor Ab).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">2 forms of TRAb – TSI (Thyroid Stimulating Immunoglobulin) and</span></p><p style=\"margin-left:48px;\"><span style=\"font-size:12.0pt;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-&nbsp; TBII (Thyroid binding Inhibitory Immunoglobulin)</span></p><p style=\"margin-left:48px;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Radioactive Iodine Uptake:</strong> This test helps to differentiate between various causes of hyperthyroidism, such as Graves' disease and toxic multinodular goiter. It is not the first step but follows initial thyroid function tests if hyperthyroidism is confirmed.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Anti thyroid peroxidase antibody:</strong> This antibody is not specific for Graves' disease. It is more commonly associated with Hashimoto's thyroiditis and other autoimmune thyroid disorders, making it less relevant for initial evaluation in this context.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The first and most crucial test in the evaluation of suspected hyperthyroidism, such as in a case suggestive of Graves' disease, is the measurement of ultrasensitive thyrotropin (TSH) levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Confirmatory Diagnosis – by TRAbs (Thyroid receptor antibodies)</span></p>",
      "correct_choice_id": 80959,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "InvestigationBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11303,
      "choices": [
        {
          "id": 45178,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dabigatran</span></span></p>"
        },
        {
          "id": 45179,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aspirin 150mg</span></span></p>"
        },
        {
          "id": 45180,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oral warfarin</span></span></p>"
        },
        {
          "id": 45181,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aspirin + Clopidogrel</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 20-year-old woman presents with breathlessness and chest pain. She is a known case of mitral stenosis. Her pulse is irregularly irregular. No thrombus is seen on echocardiography. What can be done to prevent future thrombotic events?</span></span> <span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(NEET PG 2021)</span></span></p>",
      "unique_key": "Q2430087",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365412,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C. Oral warfarin</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient is diagnosed with mitral stenosis and has an irregularly irregular pulse, indicating atrial fibrillation (AF). Atrial fibrillation is a common complication in patients with mitral stenosis and significantly increases the risk of thromboembolic events.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Long-term anticoagulation therapy is essential in such patients to prevent these events. The presence of mitral stenosis, particularly moderate to severe, mandates the use of oral anticoagulants. Warfarin is the recommended anticoagulant in this scenario because it is the only approved medication for patients with mitral stenosis and those with mechanical prosthetic heart valves.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Other anticoagulants, such as Direct Oral Anticoagulants (DOACs), are not recommended in patients with valvular atrial fibrillation (AF associated with mitral stenosis or mechanical heart valves).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Additional Information &ndash;</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">CHA2DS2-VASc score</span></strong><span style=\"font-size:12.0pt\"> to guide anticoagulation therapy in patients without mitral stenosis or a prosthetic valve.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">C</span></strong><span style=\"font-size:12.0pt\"> - Congestive heart failure: 1 point</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">H</span></strong><span style=\"font-size:12.0pt\"> - Hypertension: 1 point</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">A</span></strong><span style=\"font-size:12.0pt\"> - Age 65 to 74: 1 point, Age 75 and above: 2 points</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">D</span></strong><span style=\"font-size:12.0pt\"> - Diabetes Mellitus: 1 point</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">S2</span></strong><span style=\"font-size:12.0pt\"> - Prior stroke or TIA: 2 points</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Sex category</span></strong><span style=\"font-size:12.0pt\"> (Female): 1 point</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Vascular diseases</span></strong><span style=\"font-size:12.0pt\"> (such as coronary artery disease or peripheral artery disease): 1 point</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Scoring and Treatment Recommendations</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Total Points</span></strong><span style=\"font-size:12.0pt\">: Ranges from 0 to 9.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Score of 2 or more</span></strong><span style=\"font-size:12.0pt\">: Strongly indicates the need for long-term anticoagulation (DOAC &gt; warfarin).</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Direct Oral Anticoagulants (DOACs)</span></strong><span style=\"font-size:12.0pt\"> such as Dabigatran, Apixaban, Rivaroxaban, or Edoxaban are preferred unless the patient has conditions like mitral stenosis or mechanical prosthetic valves, in which case Warfarin might be more appropriate.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Score less than 2</span></strong><span style=\"font-size:12.0pt\">: Anticoagulation may be considered but is less mandatory.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This scoring system is crucial for making informed decisions about anticoagulation therapy to prevent stroke in patients with atrial fibrillation, tailoring treatment based on individual risk profiles.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Dabigatran:</span></strong><span style=\"font-size:12.0pt\"> Dabigatran is a DOAC that is not recommended for patients with mitral stenosis or mechanical heart valves. It is suitable for non-valvular atrial fibrillation but not for valvular AF.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Aspirin 150mg:</span></strong><span style=\"font-size:12.0pt\"> Aspirin is not sufficient as an anticoagulant in patients with atrial fibrillation, especially those with mitral stenosis. It does not provide the necessary anticoagulation to prevent thromboembolic events in such high-risk patients.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Aspirin + Clopidogrel:</span></strong><span style=\"font-size:12.0pt\"> This combination is also inadequate for anticoagulation in atrial fibrillation, particularly in patients with mitral stenosis. While it can prevent platelet aggregation, it does not provide the anticoagulation required to prevent thrombus formation in atrial fibrillation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In patients with atrial fibrillation associated with mitral stenosis, oral warfarin is the recommended anticoagulant to prevent thromboembolic events.</span></span></p>",
      "correct_choice_id": 45180,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 65805,
      "choices": [
        {
          "id": 262381,
          "text": "<p><span style=\"font-size:12.0pt;\">Pancoast tumor</span></p>"
        },
        {
          "id": 262382,
          "text": "<p><span style=\"font-size:12.0pt;\">Upper lobe pneumonia</span></p>"
        },
        {
          "id": 262383,
          "text": "<p><span style=\"font-size:12.0pt;\">Superior vena cava obstruction</span></p>"
        },
        {
          "id": 262384,
          "text": "<p><span style=\"font-size:12.0pt;\">Aspergilloma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 65-year-old chronic smoker presented with swelling of the face, difficulty breathing, and cyanosis over the upper chest and neck region. He also reported prominent veins on his chest. The chest X-ray is given below. What is the most likely diagnosis? <i>(Twisted PYQ)</i></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><i><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Picture1_7yJOj70.png\" width=\"207\" height=\"246\"></i></span></p>",
      "unique_key": "Q2877390",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365403,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Superior vena cava obstruction</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p><br><span style=\"font-size:12.0pt;\"><strong>Superior vena cava (SVC) obstruction</strong> results from compression or invasion of the SVC by a mediastinal mass, commonly caused by malignancies such as lung cancer or lymphoma. Key features include:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Swelling of the face, neck, and upper chest (venous engorgement):</strong> Due to impaired venous return to the heart.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Cyanosis over the upper chest and neck:</strong> Caused by venous stasis.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Prominent veins on the chest wall:</strong> Resulting from collateral circulation to bypass the obstructed SVC.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Chest X-ray findings:</strong> Often show a mediastinal mass or other signs of obstruction.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Pancoast tumor:</strong> Incorrect because while Pancoast tumors can cause local neurological symptoms (e.g., Horner's syndrome or brachial plexus involvement), they are not classically associated with SVC obstruction symptoms like facial swelling or cyanosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Upper lobe pneumonia:</strong> Incorrect because pneumonia causes consolidation and symptoms like fever and productive cough, rather than venous congestion or prominent chest veins.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Aspergilloma:</strong> Incorrect because aspergillomas are localized fungal balls in pre-existing cavities and do not cause symptoms of venous obstruction or facial swelling.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Superior vena cava obstruction is characterized by facial and upper body swelling, cyanosis, and prominent chest veins due to impaired venous drainage. It is commonly associated with malignancies compressing the SVC and can be identified on imaging as a mediastinal mass.</span></p>",
      "correct_choice_id": 262383,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24763,
      "choices": [
        {
          "id": 99013,
          "text": "<p><span style=\"font-size:11.0pt;\">2, 4 only</span></p>"
        },
        {
          "id": 99014,
          "text": "<p><span style=\"font-size:11.0pt;\">1, 3 only</span></p>"
        },
        {
          "id": 99015,
          "text": "<p><span style=\"font-size:11.0pt;\">1, 2 ,3,4</span></p>"
        },
        {
          "id": 99016,
          "text": "<p><span style=\"font-size:11.0pt;\">1, 2, 3</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient presents with severe vomiting and diarrhea and has orthostatic hypotension. What metabolic abnormalities would you expect in this patient? (INICET MAY 2023)</span></p><p>&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">1.Hypokalemia</span></p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">2.Hypochloremia</span></p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">3.Metabolic alkalosis</span></p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">4.Respiratory alkalosis</span></p>",
      "unique_key": "Q8200355",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365423,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D)&nbsp;1, 2, 3</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Severe vomiting and diarrhea can lead to multiple metabolic abnormalities: Hypokalemia, Hypochloremia, metabolic alkalosis with hyponatremia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">1. <strong>Hypokalemia</strong>: Loss of potassium through vomiting and diarrhea.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">2. <strong>Hypochloremia</strong>: Loss of chloride.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">3.<strong> Metabolic alkalosis</strong>: Loss of gastric acids.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">These changes are due to the loss of electrolytes and fluids.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">4. <strong>Respiratory alkalosis </strong>involves hyperventilation and a decrease in carbon dioxide, which is unrelated to the described condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Severe vomiting and diarrhea typically cause hypokalemia, hypochloremia, and metabolic alkalosis.</span></p>",
      "correct_choice_id": 99016,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11696,
      "choices": [
        {
          "id": 46750,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">First degree of heart block</span></span></span></span></p>"
        },
        {
          "id": 46751,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">AR</span></span></span></span></p>"
        },
        {
          "id": 46752,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Calcified valve</span></span></span></span></p>"
        },
        {
          "id": 46753,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mild MS</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Disappearance of loud S1 in mitral stenosis occurs in all except: (AIIMS NOV 2018)</span></span></span></span></p>",
      "unique_key": "Q5302971",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365416,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Mild MS. </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Loud S1 can be heard in mild MS also because loud S1 does not depend on severity of MS. </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Loud S1 is one of the auscultatory hallmarks of MS, however it can be attenuated in a variety of conditions: </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Associated MR</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Long PR (first degree heart block)</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CCF</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Severe AR- regurgitant jet may impinge on AML</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Calcified valve </span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. First degree heart block:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Here, the prolonged PR interval delays the closure of the mitral valve relative to ventricular contraction, often softening or eliminating the loud S1.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. AR (Aortic Regurgitation):&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The regurgitant flow in aortic regurgitation can prevent the mitral valve leaflets from closing tightly and sharply, thus softening the S1.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Calcified valve:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Calcification of the mitral valve leads to stiffening of the leaflets, which inhibits their rapid movement and thus reduces the intensity of S1.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In mitral stenosis, a loud S1 is typically present unless there is an associated condition that affects the mobility or timing of the mitral valve leaflet closure, such as calcification, regurgitation in other valves, or disturbances in electrical conduction that affect heart rhythm</span></span></span></span></p>",
      "correct_choice_id": 46753,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 65804,
      "choices": [
        {
          "id": 262377,
          "text": "<p><span style=\"font-size:12.0pt;\">Fasciculations</span></p>"
        },
        {
          "id": 262378,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyper-reflexia</span></p>"
        },
        {
          "id": 262379,
          "text": "<p><span style=\"font-size:12.0pt;\">Spasticity</span></p>"
        },
        {
          "id": 262380,
          "text": "<p><span style=\"font-size:12.0pt;\">Babinski sign</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is seen in LMN (Lower Motor Neuron) weakness? <i>(Twisted PYQ)</i></span></p>",
      "unique_key": "Q3973056",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365400,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Fasciculations</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p><br><span style=\"font-size:12.0pt;\"><strong>Lower Motor Neuron (LMN) lesions</strong> result from damage to the motor neurons that directly innervate skeletal muscles. Key features include:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Fasciculations:</strong> Visible involuntary contractions of muscle fibers caused by spontaneous firing of denervated motor units, a hallmark of LMN lesions.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Muscle atrophy:</strong> Prominent due to denervation and lack of use.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Hypotonia and hypo-reflexia:</strong> Decreased muscle tone and diminished deep tendon reflexes due to the loss of excitatory input to the reflex arc.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Hyper-reflexia:</strong> Incorrect because hyper-reflexia is a hallmark of UMN lesions, not LMN lesions, due to loss of cortical inhibitory control.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Spasticity:</strong> Incorrect because spasticity (velocity-dependent increase in muscle tone) is characteristic of UMN lesions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Babinski sign:</strong> Incorrect because the Babinski sign is a finding of UMN lesions, where there is an upgoing big toe on plantar stimulation, absent in LMN lesions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Fasciculations are a hallmark feature of LMN lesions, distinguishing them from UMN lesions, which are characterized by hyper-reflexia, spasticity, and the Babinski sign. LMN lesions result in muscle atrophy and reduced reflexes due to loss of neuronal input to muscles.</span></p>",
      "correct_choice_id": 262377,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 48173,
      "choices": [
        {
          "id": 192287,
          "text": "<p><span style=\"font-size:12.0pt;\">Pericardial Effusion</span></p>"
        },
        {
          "id": 192288,
          "text": "<p><span style=\"font-size:12.0pt;\">Constrictive Pericarditis</span></p>"
        },
        {
          "id": 192289,
          "text": "<p><span style=\"font-size:12.0pt;\">Aortic Regurgitation</span></p>"
        },
        {
          "id": 192290,
          "text": "<p><span style=\"font-size:12.0pt;\">Mitral Stenosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Auenbrugger’s sign is seen in: (NEET PG 2017)</span></p>",
      "unique_key": "Q9232751",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365415,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><strong>Ans. A) Pericardial Effusion</strong></p><p>&nbsp;</p><p><strong>Explanation:</strong></p><p>&nbsp;</p><p>Auenbrugger's sign refers to dullness in the left posterior lung field (at the base) that is seen in patients with large pericardial effusions. This is also known as <strong>Ewart's sign</strong>. When the pericardium expands due to fluid accumulation, it causes minicollapse and dullness in the left posterior lung field, which can be detected on percussion examination. This physical finding is characteristic of significant pericardial effusions.</p><p>&nbsp;</p><p><strong>&nbsp;Other Options:&nbsp;</strong></p><p>&nbsp;</p><p><strong>Option B. Constrictive Pericarditis</strong>: Constrictive pericarditis presents with signs of right heart failure, increased JVP with prominent x and y descent, pericardial knock, and Kussmaul's sign (no respiratory variation of JVP). Auenbrugger's sign is not a feature of constrictive pericarditis.</p><p>&nbsp;</p><p><strong>Option C. Aortic Regurgitation</strong>: Aortic regurgitation typically presents with wide pulse pressure, diastolic murmur, and signs of left ventricular volume overload. Auenbrugger's sign is not associated with this valvular condition.</p><p>&nbsp;</p><p><strong>Option D. Mitral Stenosis</strong>: Mitral stenosis typically presents with symptoms of pulmonary congestion, a diastolic murmur, and possible atrial fibrillation. Auenbrugger's sign is not a feature of mitral stenosis.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Auenbrugger's sign (also known as Ewart's sign) is a physical finding characterized by dullness in the left posterior lung field due to compression by an enlarged pericardium in patients with large pericardial effusions.</span></p>",
      "correct_choice_id": 192287,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 65803,
      "choices": [
        {
          "id": 262373,
          "text": "<p><span style=\"font-size:12.0pt;\">Post-streptococcal glomerulonephritis</span></p>"
        },
        {
          "id": 262374,
          "text": "<p><span style=\"font-size:12.0pt;\">Urinary tract infection</span></p>"
        },
        {
          "id": 262375,
          "text": "<p><span style=\"font-size:12.0pt;\">Bladder calculi</span></p>"
        },
        {
          "id": 262376,
          "text": "<p><span style=\"font-size:12.0pt;\">Minimal change disease</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 10-year-old child presents with brown-colored urine, generalized edema, and fatigue for the last 5 days. Investigations reveal 4+ proteinuria, hypoalbuminemia, and no red blood cells on microscopy. What is the most likely diagnosis? <i>(Twisted PYQ)</i></span></p>",
      "unique_key": "Q8402740",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365399,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Answer: D. Minimal change disease</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p><br><span style=\"font-size:12.0pt;\"><strong>Minimal change disease (MCD)</strong> is the most likely diagnosis based on the following:</span></p><ul><li><span style=\"font-size:12.0pt;\"><strong>Brown-colored urine:</strong> May result from concentrated proteinuria rather than hematuria.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Generalized edema:</strong> A hallmark of nephrotic syndrome caused by hypoalbuminemia and low oncotic pressure.</span></li><li><span style=\"font-size:12.0pt;\"><strong>4+ proteinuria and hypoalbuminemia:</strong> These findings are classic for nephrotic syndrome, commonly associated with MCD in children.</span></li><li><span style=\"font-size:12.0pt;\"><strong>No red blood cells:</strong> This rules out hematuria of glomerular origin, such as in post-streptococcal glomerulonephritis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Post-streptococcal glomerulonephritis:</strong> Incorrect because PSGN typically presents with hematuria (dysmorphic RBCs), moderate proteinuria, and no significant hypoalbuminemia or edema unless nephrotic syndrome overlaps.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Urinary tract infection:</strong> Incorrect because UTI is usually associated with pyuria, bacteriuria, and isomorphic RBCs, not heavy proteinuria or hypoalbuminemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Bladder calculi:</strong> Incorrect because bladder calculi typically present with hematuria (isomorphic RBCs) and symptoms like dysuria or frequency, not nephrotic-range proteinuria or hypoalbuminemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Minimal change disease is a common cause of nephrotic syndrome in children, characterized by heavy proteinuria, hypoalbuminemia, and generalized edema. It typically lacks hematuria, distinguishing it from glomerulonephritis.</span></p>",
      "correct_choice_id": 262376,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47603,
      "choices": [
        {
          "id": 190023,
          "text": "<p><span style=\"font-size:12.0pt;\">Electrical alternans</span></p>"
        },
        {
          "id": 190024,
          "text": "<p><span style=\"font-size:12.0pt;\">Atrial tachycardia</span></p>"
        },
        {
          "id": 190025,
          "text": "<p><span style=\"font-size:12.0pt;\">First degree AV block</span></p>"
        },
        {
          "id": 190026,
          "text": "<p><span style=\"font-size:12.0pt;\">Stokes-Adams Syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">An old man has recurrent fainting episodes. His ECG shows P-waves at 75/min, QRS complexes are at 35 bpm. The clinical diagnosis is:&nbsp;</span>(FMGE JANUARY 2024)</p>",
      "unique_key": "Q6682207",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365446,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Stokes-Adams Syndrome</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient has recurrent fainting episodes, and his ECG shows a discrepancy between the rate of P-waves (75/min) and QRS complexes (35 bpm), indicating an AV block.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In this case, the P-waves are getting blocked at the AV node, leading to fewer QRS complexes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Stokes-Adams Syndrome refers to recurrent fainting/ syncopal episodes caused by sudden fluctuations in cardiac output, paroxysmal Bradycardia often due to AV blocks such as complete heart block or second-degree AV block (Mobitz type II).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Electrical alternans:&nbsp;</strong>This is seen in cardiac tamponade and is characterized by beat-to-beat variations in QRS amplitude or axis. The patient would present with signs of tamponade such as hypotension, muffled heart sounds, and jugular venous distension, which is not the case here.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Atrial tachycardia:&nbsp;</strong>This would present with a ventricular response rate of more than 100 bpm and would typically involve abnormal P-wave morphology. The patient in this case has bradycardia (QRS at 35 bpm), excluding atrial tachycardia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. First degree AV block:&nbsp;</strong>This is characterized by a prolonged PR interval with a 1:1 P to QRS ratio. The discrepancy between P-wave and QRS complex rates in this case excludes first degree AV block.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Stokes-Adams Syndrome involves recurrent fainting episodes due to sudden changes in cardiac output, typically from AV block-related bradycardia. Recognizing the discrepancy between atrial and ventricular rates is crucial for diagnosis.</span></p>",
      "correct_choice_id": 190026,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24762,
      "choices": [
        {
          "id": 99009,
          "text": "<p><span style=\"font-size:11.0pt;\">Azithromycin</span></p>"
        },
        {
          "id": 99010,
          "text": "<p><span style=\"font-size:11.0pt;\">Ceftriaxone plus azithromycin</span></p>"
        },
        {
          "id": 99011,
          "text": "<p><span style=\"font-size:11.0pt;\">Amoxicillin plus clavulanic acid</span></p>"
        },
        {
          "id": 99012,
          "text": "<p><span style=\"font-size:11.0pt;\">Piperacillin Tazobactam plus ciprofloxacin</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A patient in emergency has the following lab parameters: creatinine 1.5 and BUN 45. The chest x-ray is shown below. In gram staining and culture only, rhinovirus was isolated. The patient is shifted to ICU. What is the treatment of choice in this patient? (INICET MAY 2023)</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/13/whatsapp-image-2024-09-13-at-103848-am_uLaNUaB.jpeg\" alt=\"\" width=\"300\" height=\"212\"></span></p>",
      "unique_key": "Q9499007",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365424,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B)&nbsp;Ceftriaxone plus azithromycin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The patient is diagnosed with <strong>community-acquired pneumonia (CAP)</strong> and has been shifted to the ICU. The treatment of choice for ICU-admitted patients with CAP includes a <strong>beta-lactam antibiotic</strong> like beta-lactam/beta-lactamase inhibitor (BL/BLI) combination like amoxicillin-clavulanic acid or piperacillin-tazobactam, or a third-generation cephalosporin like ceftriaxone combined with azithromycin or a respiratory fluoroquinolone such as levofloxacin or moxifloxacin should be administered.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Ceftriaxone are used to cover typical bacteria, while azithromycin covers atypical bacteria and provides additional anti-inflammatory properties.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Azithromycin</strong>: Insufficient as monotherapy in ICU settings.</span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Amoxicillin plus clavulanic acid:</strong> Lacks coverage for atypical pathogens alone.</span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Piperacillin Tazobactam plus ciprofloxacin</strong>: Ciprofloxacin is not a respiratory fluoroquinolone.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The combination of a beta-lactam antibiotic and azithromycin is the treatment of choice for ICU-admitted patients with community-acquired pneumonia.</span></p>",
      "correct_choice_id": 99010,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11522,
      "choices": [
        {
          "id": 46054,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Aspergillus Niger - Voriconazole</span></span></span></p>"
        },
        {
          "id": 46055,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Aspergillus fumigatus - Micafungin</span></span></span></p>"
        },
        {
          "id": 46056,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Candida albicans - Amphotericin B</span></span></span></p>"
        },
        {
          "id": 46057,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Candida Krusei&ndash; Fluconazole</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identify the correct &#39;organism-drug to which it is intrinsically resistant&#39; pair: (INICET MAY 2021)</span></span></p>",
      "unique_key": "Q4740923",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365393,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans.&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">D) Candida Krusei- Fluconazole</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Candida Krusei is known to be intrinsically resistant to fluconazole, which is a widely used antifungal agent. This resistance is due to the specific genetic and biochemical characteristics of C. Kruse, which include efflux pumps that actively expel the drug and alterations in the target enzyme of fluconazole, making it less effective.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Aspergillus Niger - Voriconazole:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Aspergillus Niger is not intrinsically resistant to voriconazole; in fact, voriconazole is one of the treatments of choice for Aspergillus infections.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Aspergillus fumigatus - Micafungin:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Aspergillus fumigatus is sensitive to echinocandins, including micafungin. It is not intrinsically resistant to this drug.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Candida albicans - Amphotericin B:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Candida albicans is sensitive to amphotericin B, which is a broad-spectrum antifungal with a wide range of activity against various fungal species.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Candida Krusei is intrinsically resistant to fluconazole.</span></span></span></p>",
      "correct_choice_id": 46057,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20251,
      "choices": [
        {
          "id": 80965,
          "text": "<p><span style=\"font-size:12.0pt;\">Aortic Regurgitation</span></p>"
        },
        {
          "id": 80966,
          "text": "<p><span style=\"font-size:12.0pt;\">Mitral Regurgitation</span></p>"
        },
        {
          "id": 80967,
          "text": "<p><span style=\"font-size:12.0pt;\">Mitral Stenosis</span></p>"
        },
        {
          "id": 80968,
          "text": "<p><span style=\"font-size:12.0pt;\">Aortic Stenosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Among the given options, murmur given in the image is associated with? (NEET PG 2023)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/29/whatsapp-image-2023-06-12-at-1901276.jpg\" alt=\"\" width=\"400\" height=\"70\"></span></p>",
      "unique_key": "Q7877972",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365406,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Mitral Regurgitation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The image provided indicates a murmur occurring between S1 and S2, which is described as <strong>a pan-systolic murmur</strong>. This type of murmur spans the entirety of systole.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Mitral Regurgitation</strong> produces a pan-systolic murmur due to the backward flow of blood from the left ventricle into the left atrium throughout systole.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Aortic Regurgitation:</strong> Characterized by an <strong>early diastolic murmur</strong> due to backflow of blood from the aorta into the left ventricle.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Mitral Stenosis:</strong> Characterized by a <strong>mid-diastolic murmur</strong> due to obstructed blood flow from the left atrium to the left ventricle during diastole.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Aortic Stenosis:</strong> Characterized by an <strong>ejection systolic murmur</strong> due to turbulent blood flow across a narrowed aortic valve during systole.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Mitral regurgitation is associated with a pan-systolic murmur, which is present throughout the systole and heard between the S1 and S2 heart sounds.</span></p>",
      "correct_choice_id": 80966,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 48202,
      "choices": [
        {
          "id": 192403,
          "text": "<p><span style=\"font-size:12.0pt;\">Large volume stool</span></p>"
        },
        {
          "id": 192404,
          "text": "<p><span style=\"font-size:12.0pt;\">Urgency</span></p>"
        },
        {
          "id": 192405,
          "text": "<p><span style=\"font-size:12.0pt;\">Tenesmus</span></p>"
        },
        {
          "id": 192406,
          "text": "<p><span style=\"font-size:12.0pt;\">Mucus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Large bowel colonic diarrhea is associated with all of the following, except: (NEET PG 2014)</span></p>",
      "unique_key": "Q1381082",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365429,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Large volume stool</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Large bowel colonic diarrhea is typically associated with frequent, small-volume stools due to the reduced reservoir capacity of the colon. The other associated features include urgency, tenesmus, and mucus in the stool. In contrast, large-volume stools are characteristic of small bowel (right-sided) diarrhea.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Right-Sided (Small Bowel) Diarrhea:</span></p><ul><li><span style=\"font-size:12.0pt;\">Reservoir Capacity: Intact</span></li><li><span style=\"font-size:12.0pt;\">Stool Volume: Large</span></li><li><span style=\"font-size:12.0pt;\">Increase in Number of Stools: Modest</span></li><li><span style=\"font-size:12.0pt;\">Urgency: Absent</span></li><li><span style=\"font-size:12.0pt;\">Tenesmus: Absent</span></li><li><span style=\"font-size:12.0pt;\">Mucus: Absent</span></li><li><span style=\"font-size:12.0pt;\">Blood: Absent</span></li><li><span style=\"font-size:12.0pt;\">Proctosigmoidoscopy: Usually Normal</span></li><li><span style=\"font-size:12.0pt;\">Mechanism: Non-Specific</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Left-Sided (Large Bowel) Diarrhea:</span></p><ul><li><span style=\"font-size:12.0pt;\">Reservoir Capacity: Decreased</span></li><li><span style=\"font-size:12.0pt;\">Stool Volume: Small</span></li><li><span style=\"font-size:12.0pt;\">Increase in Number of Stools: Large</span></li><li><span style=\"font-size:12.0pt;\">Urgency: Present</span></li><li><span style=\"font-size:12.0pt;\">Tenesmus: Present</span></li><li><span style=\"font-size:12.0pt;\">Mucus: Present</span></li><li><span style=\"font-size:12.0pt;\">Blood: Present</span></li><li><span style=\"font-size:12.0pt;\">Proctosigmoidoscopy: Usually Confirms Inflammation</span></li><li><span style=\"font-size:12.0pt;\">Mechanism: Usually Exudative</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B.</strong> <strong>Urgency</strong>: Urgency is a common symptom of large bowel colonic diarrhea due to inflammation and reduced reservoir capacity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C.</strong> <strong>Tenesmus</strong>: Tenesmus, a sensation of incomplete evacuation, is also common in large bowel colonic diarrhea.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.</strong> <strong>Mucus</strong>: Mucus in the stool is typically present in large bowel colonic diarrhea, indicating inflammation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Large bowel colonic diarrhea is characterized by frequent, small-volume stools, urgency, tenesmus, and mucus. Large-volume stools are not associated with large bowel colonic diarrhea but are seen in small bowel (right-sided) diarrhea.</span></p>",
      "correct_choice_id": 192403,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11240,
      "choices": [
        {
          "id": 44926,
          "text": "<p><span style=\"font-size:12.0pt;\">IV verapamil</span></p>"
        },
        {
          "id": 44927,
          "text": "<p><span style=\"font-size:12.0pt;\">IV adenosine</span></p>"
        },
        {
          "id": 44928,
          "text": "<p><span style=\"font-size:12.0pt;\">Carotid massage</span></p>"
        },
        {
          "id": 44929,
          "text": "<p><span style=\"font-size:12.0pt;\">Synchronized cardioversion</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 65-year-old female patient is brought to the ER in a state of unconsciousness. Her BP is 70/50 mm of Hg and her ECG is shown below. What is the next best step in the management of her condition?</span> <span style=\"font-size:12.0pt;\">(NEET PG 2019)</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/01/screenshot-2024-10-01-144116.png\" alt=\"\" width=\"400\" height=\"203\"></p>",
      "unique_key": "Q6475864",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365441,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. Synchronized cardioversion</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Any <strong>hemodynamically unstable rhythm, requires synchronized cardioversion</strong> (Shock delivered in sync with R wave <strong>to prevent R-on-T phenomenon</strong>)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A:&nbsp;</strong>AV Nodal blockers are used if <i>hemodynamically stable.</i></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B:&nbsp;</strong>Maximum of 30mg of adenosine can be tried if patient is <i>Hemodynamically Stable.</i></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C:&nbsp;</strong>Carotid massage is not recommended for hemodynamically unstable patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/23/screenshot-2024-07-23-110009.jpg\" alt=\"\" width=\"1000\" height=\"353\"></strong></span></p>",
      "correct_choice_id": 44929,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55422,
      "choices": [
        {
          "id": 221149,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Anemia of chronic disease</span></span>&nbsp;&nbsp;&nbsp;&nbsp;</p>"
        },
        {
          "id": 221150,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Aplastic crisis</span></span></p>"
        },
        {
          "id": 221151,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Hemolytic anemia</span></span></p>"
        },
        {
          "id": 221152,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Pernicious anemia</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A 45-year-old patient presented with weakness and fatigue. Lab reports showed low Hb and high reticulocyte count. WBC and platelet counts were normal. What is the likely diagnosis? (FMGE JULY 2024)</span></span></p>",
      "unique_key": "Q6856174",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365421,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. C) Hemolytic anemia</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The presence of a high reticulocyte count in the context of anemia indicates that the bone marrow is responding appropriately by producing more red blood cells to compensate for the anemia. This is a typical finding in hemolytic anemia, where there is increased destruction of red blood cells in the periphery, leading to an increase in reticulocyte production as the bone marrow attempts to replace the lost cells.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. Anemia of chronic disease:</strong> This type of anemia is typically characterized by a low reticulocyte count due to impaired erythropoiesis in response to chronic inflammation or disease.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Aplastic crisis:</strong> In aplastic crisis, there is a failure of the bone marrow to produce sufficient blood cells, leading to low reticulocyte counts, along with low white blood cell and platelet counts.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Pernicious anemia:</strong> This is caused by vitamin B12 deficiency, leading to impaired DNA synthesis and resulting in megaloblastic anemia. It typically presents with low reticulocyte counts and can also affect white blood cells and platelets, causing</span></span><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"> pancytopenia.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">In cases of anemia with a high reticulocyte count and normal white blood cell and platelet counts, hemolytic anemia is the likely diagnosis, indicating increased peripheral destruction of red blood cells and a compensatory increase in reticulocyte production by the bone marrow.</span></span></p>",
      "correct_choice_id": 221151,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11304,
      "choices": [
        {
          "id": 45182,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Methylprednisolone</span></span></p>"
        },
        {
          "id": 45183,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Heparin</span></span></p>"
        },
        {
          "id": 45184,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Torsemide</span></span></p>"
        },
        {
          "id": 45185,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Terlipressin plus albumin</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A chronic alcoholic male patient presents with abdominal distension, reduced urine output, and pedal edema. His serum creatinine was 1.6 mg/dL. What is the next line of management in this patient?</span> <span style=\"font-size:12.0pt\">(NEET PG 2021)</span></span></span></p>",
      "unique_key": "Q3208063",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365413,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D. Terlipressin plus albumin</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient described has cirrhosis with signs of renal dysfunction, which suggests the possibility of hepatorenal syndrome (HRS) <strong>(Remember - HRS is the diagnosis of exclusion)</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">HRS is a type of renal failure that occurs in patients with advanced liver disease and is characterized by functional renal failure due to reduced renal blood flow.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The initial management for suspected HRS involves <strong>stopping all diuretics</strong>, as they can exacerbate renal dysfunction. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The mainstay of treatment includes the <strong>administration of albumin</strong> to expand plasma volume and <strong>vasoconstrictors </strong>to improve renal blood flow. Terlipressin is a vasoconstrictor that is commonly used in combination with albumin to manage HRS. This combination helps to improve renal function by counteracting the splanchnic vasodilation that occurs in cirrhosis, thereby increasing effective arterial blood volume and renal perfusion.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Doses &ndash; </span></strong><span style=\"font-size:12.0pt\">The prescribed dose of albumin is 1 gram per kilogram of body weight per day. The maximum dose should not exceed 100 grams per day. Albumin should be administered for at least 48 hours, equivalent to 2 days. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It&#39;s important to avoid using normal saline or lactated solutions concurrently because they contain sodium, which could be contraindicated or undesirable in the treatment circumstances requiring albumin.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Methylprednisolone:</span></strong><span style=\"font-size:12.0pt\"> Methylprednisolone is a corticosteroid and is not indicated in the treatment of hepatorenal syndrome. It is used for conditions such as autoimmune hepatitis or severe alcoholic hepatitis, but it does not address the pathophysiology of HRS.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Heparin:</span></strong><span style=\"font-size:12.0pt\"> Heparin is an anticoagulant and is not appropriate in this setting due to the increased risk of bleeding in patients with cirrhosis. It is used for preventing or treating thrombotic conditions but does not play a role in managing HRS.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Torsemide:</span></strong><span style=\"font-size:12.0pt\"> Torsemide is a loop diuretic and should be discontinued in patients with HRS. Diuretics can worsen renal function in these patients by further decreasing renal perfusion and exacerbating the underlying problem of splanchnic vasodilation and renal vasoconstriction.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In patients with cirrhosis and suspected hepatorenal syndrome, the appropriate management includes the use of albumin combined with vasoconstrictors like terlipressin to improve renal function and address the underlying hemodynamic changes associated with HRS.</span></span></span></p>",
      "correct_choice_id": 45185,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50947,
      "choices": [
        {
          "id": 203329,
          "text": "<p><span style=\"font-size:12.0pt;\">Total T3&nbsp;</span></p>"
        },
        {
          "id": 203330,
          "text": "<p><span style=\"font-size:12.0pt;\">Thyroid scan&nbsp;</span></p>"
        },
        {
          "id": 203331,
          "text": "<p><span style=\"font-size:12.0pt;\">Free T4&nbsp;</span></p>"
        },
        {
          "id": 203332,
          "text": "<p><span style=\"font-size:12.0pt;\">TSH&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 27-year-old female patient presents with weight loss, anxiety, tachycardia, and restlessness. The resting pulse was 110 beats per minute. Which of the following tests should be done next to evaluate her condition further? (</span><span style=\"background-color:rgb(255,255,255);color:rgb(111,126,149);font-size:14px;\">INICET Nov 2023</span><span style=\"font-size:12.0pt;\">)</span></p>",
      "unique_key": "Q4137222",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365394,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) TSH</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p><span style=\"font-size:10pt;\"><strong>&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\">In the evaluation of suspected thyroid dysfunction, the initial and most crucial test is the measurement of Thyroid-Stimulating Hormone (TSH). TSH is the most sensitive indicator of thyroid function because even minor changes in thyroid hormone levels cause significant changes in TSH levels due to the feedback mechanism between the thyroid gland and the pituitary gland. Elevated or suppressed TSH levels provide clear insight into whether the thyroid gland is underactive (hypothyroidism) or overactive (hyperthyroidism). Given the patient's symptoms of weight loss, anxiety, tachycardia, and restlessness, hyperthyroidism is suspected, making TSH the appropriate initial test.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. &nbsp;Total T3:</strong>&nbsp;T3 levels can be influenced by various factors and are usually measured after initial TSH and Free T4 tests suggest hyperthyroidism.</span></p><p><span style=\"font-size:10pt;\"><strong>&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>Option B. &nbsp;Thyroid Scan:&nbsp;</strong>This imaging test evaluates thyroid structure and function, useful in cases where nodules or hyperactivity need to be assessed. It is not the first-line test for evaluating general thyroid function.</span></p><p><span style=\"font-size:10pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Free T4:&nbsp;</strong>Free T4 is important in assessing thyroid function and is typically measured alongside TSH. However, TSH is preferred as the initial screening test due to its sensitivity in detecting thyroid dysfunction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The initial test for evaluating suspected thyroid dysfunction, particularly in hyperthyroid symptoms, is TSH due to its sensitivity and reliability in reflecting thyroid status.</span></p>",
      "correct_choice_id": 203332,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 65802,
      "choices": [
        {
          "id": 262369,
          "text": "<p><span style=\"font-size:12.0pt;\">Sensory aphasia</span></p>"
        },
        {
          "id": 262370,
          "text": "<p><span style=\"font-size:12.0pt;\">Motor aphasia</span></p>"
        },
        {
          "id": 262371,
          "text": "<p><span style=\"font-size:12.0pt;\">Anomic aphasia</span></p>"
        },
        {
          "id": 262372,
          "text": "<p><span style=\"font-size:12.0pt;\">Conduction aphasia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient is brought to the OPD with complaints of difficulty repeating sentences accurately, despite fluent speech and good comprehension. The family reports that these symptoms began suddenly. Which type of aphasia does the patient most likely have? <i>(Twisted PYQ)</i></span></p>",
      "unique_key": "Q2157324",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365398,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. Conduction aphasia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p><br><span style=\"font-size:12.0pt;\"><strong>Conduction aphasia</strong> is characterized by the following:</span></p><ul><li><span style=\"font-size:12.0pt;\"><strong>Fluent speech:</strong> The patient can speak fluently without hesitation.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Good comprehension:</strong> The ability to understand spoken language is intact.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Impaired repetition:</strong> The hallmark feature of conduction aphasia is difficulty repeating sentences, caused by damage to the arcuate fasciculus, which connects Wernicke’s area (comprehension) and Broca’s area (speech production).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A: Sensory aphasia:</strong> Incorrect because sensory aphasia (Wernicke's aphasia) is characterized by impaired comprehension and nonsensical speech, which is not consistent with this patient’s preserved comprehension.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B: Motor aphasia:</strong> Incorrect because motor aphasia (Broca's aphasia) involves non-fluent, halting speech and intact comprehension, which does not fit the described fluency in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C: Anomic aphasia:</strong> Incorrect because anomic aphasia primarily involves difficulty in naming objects, without the prominent repetition issues seen here.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Conduction aphasia is caused by damage to the arcuate fasciculus, resulting in fluent speech, intact comprehension, and impaired ability to repeat sentences. This differentiates it from sensory (Wernicke’s) and motor (Broca’s) aphasias.</span></p>",
      "correct_choice_id": 262372,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54256,
      "choices": [
        {
          "id": 216493,
          "text": "<p><span style=\"font-size:12.0pt;\">NSTEMI</span></p>"
        },
        {
          "id": 216494,
          "text": "<p><span style=\"font-size:12.0pt;\">Unstable Angina</span></p>"
        },
        {
          "id": 216495,
          "text": "<p><span style=\"font-size:12.0pt;\">Posterior MI</span></p>"
        },
        {
          "id": 216496,
          "text": "<p><span style=\"font-size:12.0pt;\">Acute Myocarditis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 55-year-old man presented with chest pain and shortness of breath. An ECG was taken in the emergency and was shown. What is the likely diagnosis?&nbsp;</span>&nbsp;(INICET MAY 2024)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-101157.jpg\" alt=\"\" width=\"500\" height=\"234\"></span></p>",
      "unique_key": "Q7254253",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365443,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong> <strong>C) Posterior MI</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient's ECG shows classic signs of a posterior myocardial infarction (MI). The characteristic features of posterior MI in<strong> leads V1, V2 and (±) V3 include a</strong> <strong>tall R wave, ST depression, and upright T wave.</strong> These features suggest a mirror image of an infarction in the posterior wall of the left ventricle. While definitive diagnosis of a posterior MI typically involves additional leads (V7, V8, V9), the observed patterns in leads V2 and V3 are indicative of this condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In the provided case, the absence of ST elevation rules out an acute STEMI. NSTEMI and unstable angina can only be differentiated by cardiac biomarkers such as troponins, which are not mentioned here. Acute myocarditis would typically present with non-specific ECG changes and a relevant clinical history, such as a recent viral infection, which is not present in this scenario.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. NSTEMI:</strong>&nbsp; NSTEMI (Non-ST Elevation Myocardial Infarction) can present with similar symptoms but requires positive cardiac troponins for diagnosis. The absence of troponin data makes this diagnosis less likely.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Unstable Angina: </strong>Unstable angina presents with similar symptoms but without elevation of cardiac biomarkers. As mentioned, differentiating between NSTEMI and unstable angina is not possible without troponin levels, which are not provided.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Acute Myocarditis:</strong> Acute myocarditis would typically present with a history of viral infection and can show non-specific ECG changes, often including sinus tachycardia. The patient's history and ECG findings do not support this diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The presence of tall R waves, ST depression, and upright T waves in leads V2 and V3 are indicative of a posterior myocardial infarction.</span></p>",
      "correct_choice_id": 216495,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 48229,
      "choices": [
        {
          "id": 192511,
          "text": "<p>There is an incremental response on 2-3 Hz nerve stimulation</p>"
        },
        {
          "id": 192512,
          "text": "<p>Antibodies are directed against voltage-gated calcium channels (VGCC)</p>"
        },
        {
          "id": 192513,
          "text": "<p>Reflexes are absent or depressed</p>"
        },
        {
          "id": 192514,
          "text": "<p>Patients experience autonomic changes</p>"
        }
      ],
      "text": "<p>Which of the following statements about Lambert-Eaton Myasthenic Syndrome (LEMS) is NOT correct? (NEET PG 2015)</p>",
      "unique_key": "Q9680294",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365439,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><strong>Correct Answer:</strong> <strong>A.</strong> <strong>There is an incremental response on 2-3 Hz nerve stimulation</strong></p><p>&nbsp;</p><p><strong>Explanation:</strong></p><p>&nbsp;</p><p>Lambert-Eaton Myasthenic Syndrome (LEMS) is a presynaptic disorder of the neuromuscular junction. In LEMS, at low rates of repetitive nerve stimulation (2-3 Hz), a decremental response is observed, similar to myasthenia gravis. However, at high rates of stimulation (20-50 Hz) or following brief exercise, an incremental response occurs, which is characteristic of LEMS. This distinguishes LEMS from myasthenia gravis. LEMS is caused by autoantibodies directed against P/Q-type calcium channels at motor nerve terminals, which impair acetylcholine release.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option B. Antibodies are directed against voltage:</strong> gated calcium channels (VGCC) - This statement is correct. LEMS is caused by autoantibodies directed against P/Q-type calcium channels at the motor nerve terminals, detected in approximately 85% of LEMS patients. These autoantibodies impair the release of acetylcholine from nerve terminals.</p><p>&nbsp;</p><p><strong>Option C. Reflexes are absent or depressed:</strong> This statement is correct. In LEMS, patients have depressed or absent reflexes, which is a distinguishing feature from myasthenia gravis.</p><p>&nbsp;</p><p><strong>Option D. Patients experience autonomic changes:&nbsp;</strong>This statement is correct. LEMS patients experience autonomic changes such as dry mouth and impotence, which are characteristic features of the condition.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong></p><p>&nbsp;</p><p>In LEMS, a decremental response occurs at low rates of nerve stimulation (2-3 Hz), while an incremental response is seen at high rates of stimulation (20-50 Hz) or after brief exercise—this electrophysiologic pattern helps distinguish LEMS from myasthenia gravis.</p>",
      "correct_choice_id": 192511,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47514,
      "choices": [
        {
          "id": 189667,
          "text": "<p><span style=\"font-size:12.0pt;\">Obstructive sleep apnea</span></p>"
        },
        {
          "id": 189668,
          "text": "<p><span style=\"font-size:12.0pt;\">Narcolepsy</span></p>"
        },
        {
          "id": 189669,
          "text": "<p><span style=\"font-size:12.0pt;\">Obesity hypoventilation syndrome</span></p>"
        },
        {
          "id": 189670,
          "text": "<p><span style=\"font-size:12.0pt;\">Central sleep apnea</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 35-year-old female presents with daytime sleepiness, impaired concentration, and impaired memory. On exam, her BMI is 43, BP is 170/100 mm Hg. Her daytime ABG analysis shows HCO3 - 33 mEq/L, PaCO2 - 53 mmHg, and PaO2 - 70 mmHg. What is the most likely diagnosis?&nbsp;</span>(FMGE JULY 2023)</p>",
      "unique_key": "Q9785874",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365405,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Obesity hypoventilation syndrome</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient has obesity hypoventilation syndrome (OHS), which is characterized by the following criteria:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">A BMI of 30 or more, indicating obesity.</span></li><li><span style=\"font-size:12.0pt;\">Hypercarbia or hypercapnia, defined as PaCO2 &gt; 45 mm Hg.</span></li><li><span style=\"font-size:12.0pt;\">The awake ABG must be taken (daytime ABG).</span></li><li><span style=\"font-size:12.0pt;\">No other causes (central or peripheral neuromuscular) should be present to explain the hypercapnia.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient's symptoms and test results align with OHS. OHS patients typically present with symptoms like daytime sleepiness, impaired concentration, and impaired memory, which are noted in this patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Obstructive sleep apnea:</strong> This condition typically causes issues during sleep, not in the daytime. It is characterized by repeated episodes of partial or complete upper airway obstruction during sleep.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Narcolepsy:</strong> This is a sleep disorder characterized by excessive daytime sleepiness and sudden sleep attacks, but it does not align with the patient’s clinical picture, which includes specific ABG results and severe obesity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Central sleep apnea:</strong> Like obstructive sleep apnea, central sleep apnea occurs during sleep and involves periods of non-breathing. It does not match the daytime ABG findings of this patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Obesity hypoventilation syndrome is diagnosed based on a BMI of 30 or more, daytime hypercapnia (PaCO2 &gt; 45 mm Hg), and the absence of other causes for hypercapnia.</span></p>",
      "correct_choice_id": 189669,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50945,
      "choices": [
        {
          "id": 203321,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Furosemide</span></span></p>"
        },
        {
          "id": 203322,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carvedilol</span></span></p>"
        },
        {
          "id": 203323,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Digoxin&nbsp; </span></span></p>"
        },
        {
          "id": 203324,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Captopril</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An old man presents with dyspnea and swelling of his feet. On examination, rales are heard and he is found to have an enlarged heart on chest x-ray. Which of the following will delay the progression?</span></span></span></span></p>",
      "unique_key": "Q3027186",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365392,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Captopril </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation: </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Captopril, an ACE inhibitor, has been shown to improve survival and delay the progression of heart failure. ACE inhibitors like Captopril work by blocking the conversion of angiotensin I to angiotensin II, leading to vasodilation and reduced workload on the heart. This class of drugs is considered a cornerstone in the management of heart failure with reduced ejection fraction (HF-REF). The benefits of ACE inhibitors in heart failure are well-documented, including the 1992 study on Enalapril, which demonstrated its effectiveness as a gold standard treatment.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Furosemide:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A loop diuretic, Furosemide is effective in reducing symptoms of congestion and decreasing heart failure hospitalization rates but does not improve survival or delay disease progression.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Carvedilol:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;While Carvedilol, a non-selective beta-blocker, has mortality benefits and improves survival in heart failure patients, it is not preferred over ACE inhibitors as the first choice for delaying heart failure progression.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Digoxin:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;This medication can reduce symptoms and heart failure hospitalizations to some extent, particularly in advanced heart failure, but it does not delay disease progression or improve survival, as evidenced by trials like the DIG trial.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ACE inhibitors, such as Captopril, are essential in delaying the progression of heart failure and improving survival.</span></span></span></span></p>",
      "correct_choice_id": 203324,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16162,
      "choices": [
        {
          "id": 64608,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Negative skin tuberculin test and negative chest X-ray</span></span></p>"
        },
        {
          "id": 64609,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Positive skin tuberculin test and positive chest X-ray</span></span></p>"
        },
        {
          "id": 64610,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Positive skin tuberculin test and negative chest X-ray</span></span></p>"
        },
        {
          "id": 64611,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Negative skin tuberculin test and positive chest X-ray</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">65-year-old male presented with unexplained fever and prolonged respiratory distress despite appropriate treatment. A diagnosis of cryptic TB was made. Which of the following is the correct statement related to this condition? (FMGE JAN 2023)</span></span></span></p>",
      "unique_key": "Q7279005",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365407,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>A) Negative skin tuberculin test and negative chest X-ray</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cryptic TB is a form of disseminated </span><span style=\"font-size:12.0pt\">miliary </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">tuberculosis commonly seen in the elderly population. The term &quot;cryptic&quot; means hidden, indicating that the disease does not present with obvious clinical signs typically associated with TB. This includes a negative skin tuberculin test and no visible evidence of TB on a chest X-ray.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">&nbsp;</span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Microbiological confirmation of TB in these patients is challenging and often not possible with standard imaging techniques. Modern guidelines suggest using advanced imaging modalities like PET CT scans to detect enlarged lymph nodes in thoracic or abdominal areas, which can be sampled for confirmation. However, even with these methods, microbiological diagnosis is still difficult</span><span style=\"font-size:12.0pt\"> (DD &ndash; Malignancy). </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In such cases, empirical anti-tubercular treatment is started, and diagnosis is confirmed based on the patient&#39;s response to therapy and resolution of symptoms and lymph node enlargement over time.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">B</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">. <strong>Positive skin tuberculin test and positive chest X-ray</strong>: Incorrect. Cryptic TB does not typically present with a positive skin tuberculin test or obvious chest X-ray findings. The hidden nature of this form of TB means both tests are likely to be negative.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">C</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">. <strong>Positive skin tuberculin test and negative chest X-ray</strong>: Incorrect. As mentioned, cryptic TB results in a negative skin tuberculin test, not a positive one, because the disease does not produce a strong immune response detectable by this test.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">. <strong>Negative skin tuberculin test and positive chest X-ray</strong>: Incorrect. Cryptic TB is characterized by a lack of clear imaging evidence of TB, making a positive chest X-ray an unlikely finding.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cryptic TB is a form of disseminated tuberculosis common in the elderly, characterized by a negative skin tuberculin test and no obvious imaging evidence of TB. Diagnosis is often confirmed through empirical treatment and advanced imaging techniques.</span></span></span></p>",
      "correct_choice_id": 64608,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47947,
      "choices": [
        {
          "id": 191383,
          "text": "<p>Systemic sclerosis of the diffuse cutaneous type&nbsp;</p>"
        },
        {
          "id": 191384,
          "text": "<p>Connective tissue disease of the mixed type</p>"
        },
        {
          "id": 191385,
          "text": "<p>Syndrome characterized by CREST features</p>"
        },
        {
          "id": 191386,
          "text": "<p>Inflammatory myopathy, particularly polymyositis</p>"
        }
      ],
      "text": "<p>Which of the following conditions is most strongly associated with the presence of anti-centromere antibodies? (NEET PG 2015)</p>",
      "unique_key": "Q5986082",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365430,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><strong>Correct Answer: C. Syndrome characterized by CREST features.</strong></p><p>&nbsp;</p><p><strong>Explanation:</strong>&nbsp;</p><p>&nbsp;</p><p>Anti-centromere antibodies are highly specific for limited cutaneous systemic sclerosis (lcSSc), which is classically associated with the CREST syndrome (Calcinosis cutis, Raynaud's phenomenon, Esophageal dysmotility, Sclerodactyly, and Telangiectasia). These antibodies show a strong association with clinical features including digital ischemic ulcers, calcinosis cutis, and isolated pulmonary arterial hypertension (PAH), while renal crisis is rarely seen in patients with this antibody pattern. Anti-centromere antibodies display a discrete speckled (centromere) pattern on immunofluorescence testing.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option A. Systemic sclerosis of the diffuse cutaneous type</strong>: Diffuse cutaneous systemic sclerosis (dcSSc) is associated with anti-topoisomerase I (Scl-70) and anti-RNA polymerase III antibodies, not anti-centromere antibodies. These antibody patterns are mutually exclusive in systemic sclerosis.</p><p>&nbsp;</p><p><strong>Option B. Connective tissue disease of the mixed type</strong>: Mixed connective tissue disease (MCTD) is characterized by the presence of U1-RNP antibodies. Anti-centromere antibodies are not a serological feature of MCTD.</p><p>&nbsp;</p><p><strong>Option D. Inflammatory myopathy, particularly polymyositis</strong>: PM/Scl and anti-Jo antibodies are the serological markers associated with myositis overlap syndromes. Anti-centromere antibodies are not typically found in inflammatory myopathies.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong>&nbsp;</p><p>&nbsp;</p><p>Anti-centromere antibodies have high specificity for limited cutaneous systemic sclerosis (lcSSc) and the CREST variant, serving as important serological markers that help distinguish this clinical phenotype from other forms of systemic sclerosis and connective tissue disorders.</p>",
      "correct_choice_id": 191385,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11347,
      "choices": [
        {
          "id": 45354,
          "text": "<p><span style=\"font-size:12.0pt;\">Intravenous fluids with S.C. long-acting insulin</span></p>"
        },
        {
          "id": 45355,
          "text": "<p><span style=\"font-size:12.0pt;\">Intravenous fluids with S.C. regular insulin</span></p>"
        },
        {
          "id": 45356,
          "text": "<p><span style=\"font-size:12.0pt;\">Intravenous insulin I.V. long-acting insulin</span></p>"
        },
        {
          "id": 45357,
          "text": "<p><span style=\"font-size:12.0pt;\">Intravenous fluids with I.V. regular insulin</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A patient with diabetes mellitus for the past 5 years presents with vomiting and abdominal pain. She is non-compliant with medication and appears dehydrated. Investigations revealed a blood sugar value of 500 mg/dL and the presence of ketone bodies. What is the next best step in management? (Neet pg 2022)</span></p>",
      "unique_key": "Q2295940",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365432,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Intravenous fluids with I.V. regular insulin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In a patient presenting with diabetic ketoacidosis (DKA), the immediate management involves <strong>FLIP Therapy (fluid resuscitation, insulin therapy and Potassium management)</strong>. This patient's blood glucose is significantly elevated, and the presence of ketones indicates DKA, which is a medical emergency.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>1. Fluids</strong>: The initial step is to administer intravenous (IV) fluids to correct dehydration and stabilize the patient's hemodynamic status. The typical approach involves giving isotonic saline (0.9% sodium chloride) at a <strong>rate of 10-20 mL/kg/hr (2-3L) for the first 2-3 hours</strong>. This helps to correct hypovolemia, improve perfusion, and begin to lower blood glucose levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Criteria for fluid management</strong>: After the initial two to three hours of treatment, switch from initial fluids (typically normal saline) to half normal saline for ongoing maintenance.&nbsp;If capillary blood glucose (CBG) drops below 300 mg/dL, and specifically if it falls below 250 mg/dL, add 5% dextrose water to the regimen.</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">The purpose of adding dextrose is to maintain a target CBG range of 200 to 300 mg/dL. This range helps prevent hypoglycemia, which is a critical concern in the management process.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>2. Insulin</strong>: Insulin therapy is crucial to halt ketogenesis and reduce blood glucose levels. After 1 hr of fluid start insulin. The <strong>recommended protocol for DKA involves IV regular insulin</strong> because of its rapid onset and short duration of action. The insulin regimen follows a fixed dose insulin infusion (FDII) approach. This helps to normalize blood glucose and ketone levels efficiently.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">First option: Continuous infusion at 0.15 units/kg/hour.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Second option (<strong>more commonly used</strong>): Administer a 0.1 units/kg bolus, followed by a 0.1 units/kg/hour infusion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>IV regular insulin</strong> is preferred over subcutaneous (SC) insulin in emergency settings like DKA due to its predictable absorption and ability to be titrated easily based on frequent blood glucose monitoring.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Adjustments Based on Blood Glucose Levels</strong>: Monitor capillary blood glucose (CBG). If CBG drops below 300 mg/dL, reduce the insulin infusion to half the dose (0.05 units/kg/hour).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Criteria for Stopping Insulin Infusion</strong>: Insulin infusion can be stopped ONLY when the patient tolerates oral feeds without vomiting or abdominal pain. Other criteria include resolution of ketoacidosis, negative or trace positive plasma ketones, and an <strong>anion gap less than 12</strong>, pH more than 7.3 and serum bicarbonate more than 18.</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">Transition to subcutaneous insulin upon meeting these criteria.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Potassium</strong> Management: Potassium addition is tailored based on serum potassium levels. When serum potassium levels are within a normal range, add approximately 40 milliequivalents of potassium chloride (KCL) per liter of IV fluid administered. This ensures adequate potassium levels to prevent hypokalemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Monitoring</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">If serum potassium is below 3.3, administer IV potassium chloride (KCL) before insulin to prevent hypokalemia-induced arrhythmias.</span></li><li><span style=\"font-size:12.0pt;\">If serum potassium is between 3.3 and 5.2, administer insulin and KCL together.</span></li><li><span style=\"font-size:12.0pt;\">If serum potassium exceeds 5.3 &amp; above, administer insulin without KCL and monitor serum potassium closely.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Treatment Goals and Precautions</strong>:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Aim for a target CBG of 200 to 300 mg/dL to avoid hypoglycemia.</span></li><li><span style=\"font-size:12.0pt;\">The common causes of death in patients with DKA, particularly during the treatment phase –&nbsp;</span><ul><li><span style=\"font-size:12.0pt;\"><strong>Cerebral edema</strong> (MC) may occur due to a rapid decrease in blood glucose levels, which can lead to an osmotic shift. This shift causes fluids to move from the extracellular fluid (ECF) to the intracellular fluid (ICF), resulting in swelling of the brain tissue.</span></li><li><span style=\"font-size:12.0pt;\">2<sup>nd</sup> MC cause is <strong>Potassium Disorder</strong> esp. Hypokalemia, this can result in ventricular arrythmias.</span></li><li><span style=\"font-size:12.0pt;\">Other causes include ARDS, patients can initially develop acute kidney injury (pre-renal), later if severe, leads to ATN (Acute tubular necrosis) due to hypoperfusion of kidneys.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Intravenous fluids with S.C. long-acting insulin</strong>: Long-acting insulin is not suitable for acute management due to its prolonged action and delayed onset, making it inappropriate for rapid correction of hyperglycemia and ketonemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Intravenous fluids with S.C. regular insulin</strong>: While regular insulin is appropriate, the subcutaneous route is less effective in severe DKA where IV administration allows for better control and titration.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Intravenous insulin I.V. long-acting insulin</strong>: Long-acting insulin is never administered IV due to the risk of prolonged hypoglycemia and lack of titratability. It is also not designed for acute management settings.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In the management of diabetic ketoacidosis (DKA), the initial steps involve aggressive IV fluid resuscitation followed by IV regular insulin to rapidly lower blood glucose and resolve ketosis.</span></p>",
      "correct_choice_id": 45357,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47530,
      "choices": [
        {
          "id": 189731,
          "text": "<p><span style=\"font-size:12.0pt;\">Post-streptococcal glomerulonephritis</span></p>"
        },
        {
          "id": 189732,
          "text": "<p><span style=\"font-size:12.0pt;\">Urinary tract infection</span></p>"
        },
        {
          "id": 189733,
          "text": "<p><span style=\"font-size:12.0pt;\">Bladder calculi</span></p>"
        },
        {
          "id": 189734,
          "text": "<p><span style=\"font-size:12.0pt;\">Minimal change disease</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 10-year-old child presents with brown-colored urine, flank pain, and fatigue for the last 3 days. He has 2+ proteinuria with &gt;20 red cells/HPF and dysmorphic red blood cells. What is the most likely diagnosis? (</span><span style=\"background-color:rgb(255,255,255);color:rgb(111,126,149);font-size:14px;\">FMGE July 2023)</span></p>",
      "unique_key": "Q6741765",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365414,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Post-streptococcal glomerulonephritis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The clinical presentation of a 10-year-old child with brown-colored urine, flank pain, fatigue, significant proteinuria, and dysmorphic red blood cells suggests a diagnosis of glomerulonephritis. Among the given options, the most likely diagnosis is <strong>Post-streptococcal glomerulonephritis (PSGN)</strong>. Key points supporting this diagnosis include:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Brown-colored urine (tea or cola colored):&nbsp;</strong>Indicates hematuria.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Flank pain and fatigue:&nbsp;</strong>Common symptoms associated with glomerulonephritis.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Proteinuria and dysmorphic red blood cells:&nbsp;</strong>Indicate glomerular origin of hematuria, typical in glomerulonephritis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Urinary tract infection:&nbsp;</strong>Usually presents with <strong>isomorphic red blood cell</strong>s rather than dysmorphic red blood cells and would typically be associated with symptoms of urinary frequency, urgency, and dysuria.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Bladder calculi:&nbsp;</strong>Can cause hematuria but typically produces <strong>isomorphic red blood cells</strong>, not dysmorphic ones.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Minimal change disease:&nbsp;</strong>Usually presents with <strong>nephrotic syndrome</strong>, characterized by heavy proteinuria, hypoalbuminemia, edema, and frothy urine, rather than hematuria and dysmorphic red blood cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Post-streptococcal glomerulonephritis is a common cause of glomerulonephritis in children, presenting with hematuria, proteinuria, and dysmorphic red blood cells following a streptococcal infection.</span></p>",
      "correct_choice_id": 189731,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16164,
      "choices": [
        {
          "id": 64616,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tuberculous meningitis</span></span></span></p>"
        },
        {
          "id": 64617,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Bacterial meningitis</span></span></span></p>"
        },
        {
          "id": 64618,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Fungal meningitis</span></span></span></p>"
        },
        {
          "id": 64619,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Viral meningitis</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A patient presented with a fever for 11 days with neck rigidity. A lumbar puncture was done and it showed lymphocytes predominantly, Glucose 50 mg/dL, and protein 300 mg/dL. Gram-staining was negative. CXR of the patient shows upper lobe infiltrates with hilar lymph node enlargement. What is the diagnosis? (FMGE JAN 2023)</span></span></span></p>",
      "unique_key": "Q8906401",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365409,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>A) Tuberculous meningitis</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The patient presents with symptoms indicative of meningitis, including fever, neck rigidity, and abnormal cerebrospinal fluid (CSF) findings. The CSF shows lymphocyte predominance, low glucose (50 mg/dL), and high protein (300 mg/dL), which are hallmarks of tuberculous meningitis. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Additionally, the chest X-ray (CXR) revealing upper lobe infiltrates with hilar lymph node enlargement further supports the diagnosis of tuberculosis, as these are common findings in pulmonary tuberculosis that can spread to the meninges.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Bacterial meningitis:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Typically presents with <strong>neutrophil predominance in CSF</strong> rather than lymphocytes. The CSF glucose is also usually low, but the clinical and radiological findings here are not supportive of a bacterial etiology.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Fungal meningitis:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Can present similarly with lymphocytic CSF and abnormal glucose/protein levels. However, the CXR findings of upper lobe infiltrates and hilar lymph node enlargement strongly suggest tuberculosis rather than a fungal infection.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Viral meningitis:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Usually presents with normal glucose levels in the CSF, as viruses do not metabolize glucose. The patient&rsquo;s low CSF glucose level makes this diagnosis unlikely.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">For a patient with lymphocyte-predominant CSF, low glucose, high protein, and associated pulmonary findings such as upper lobe infiltrates with hilar lymph node enlargement, tuberculous meningitis should be highly suspected.</span></span></span></p>",
      "correct_choice_id": 64616,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11200,
      "choices": [
        {
          "id": 44766,
          "text": "<p><span style=\"font-size:12.0pt;\">Lateral medullary syndrome</span></p>"
        },
        {
          "id": 44767,
          "text": "<p><span style=\"font-size:12.0pt;\">Weber syndrome</span></p>"
        },
        {
          "id": 44768,
          "text": "<p><span style=\"font-size:12.0pt;\">Medial medullary syndrome</span></p>"
        },
        {
          "id": 44769,
          "text": "<p><span style=\"font-size:12.0pt;\">Millard Gubler syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Thrombosis of posterior inferior cerebellar artery causes? (NEET PG 2018)</span></p>",
      "unique_key": "Q8085788",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365426,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Lateral Medullary syndrome.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>LATERAL MEDULLARY SYNDROME:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/22/screenshot-2024-07-22-163123.jpg\" alt=\"\" width=\"1000\" height=\"446\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B:</strong> Weber is a medial midbrain syndrome caused by occlusion of PCA branches.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C:&nbsp;</strong>Medial medullary syndrome <strong>(aka Dejerine syndrome)</strong> supplied by vertebral/spinal artery.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D:</strong> Millard-Gubler is a lateral pontine syndrome involving <strong>peripheral LMN of 7<sup>th</sup> and 6<sup>th</sup> nerve&nbsp;</strong>(NOT NUCLEUS!) supplied by AICA.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/22/screenshot-2024-07-22-164951.jpg\" alt=\"\" width=\"500\" height=\"558\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Image showing arteries involved in brainstem syndromes lateral vs medial brainstem.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/22/screenshot-2024-07-22-163156.jpg\" alt=\"\" width=\"1000\" height=\"210\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison 21E/Chap 426/Neurology/stroke</strong></span></p>",
      "correct_choice_id": 44766,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54257,
      "choices": [
        {
          "id": 216497,
          "text": "<p><span style=\"font-size:12.0pt;\">Synchronized DC Cardioversion</span></p>"
        },
        {
          "id": 216498,
          "text": "<p><span style=\"font-size:12.0pt;\">IV Adenosine (6mg)</span></p>"
        },
        {
          "id": 216499,
          "text": "<p><span style=\"font-size:12.0pt;\">Carotid Sinus Massage</span></p>"
        },
        {
          "id": 216500,
          "text": "<p><span style=\"font-size:12.0pt;\">IV Amiodarone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A young male presented with palpitations and hence ECG was taken. ECG demonstrated narrow complex tachycardia and his BP was 70/40 mm of Hg. What is the next step in the management of this patient?&nbsp;</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q2712669",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365444,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong> <strong>A) Synchronized DC Cardioversion</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In the case of a patient presenting with palpitations, narrow complex tachycardia, and hypotension (BP 70/40 mm Hg), the patient is considered hemodynamically unstable. The appropriate management for an unstable patient with a pulse is synchronized DC cardioversion. This intervention is critical to restore normal rhythm promptly and prevent deterioration.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Synchronized cardioversion delivers a shock that is timed with the QRS complex, preventing the shock from falling on the T wave, which could induce ventricular fibrillation. This is the standard treatment for unstable supraventricular tachycardia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. IV Adenosine (6mg):</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">IV Adenosine is used for the treatment of stable narrow complex tachycardia. It is not appropriate for an unstable patient due to its transient effect and the need for rapid intervention in unstable conditions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Carotid Sinus Massage:</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">Carotid sinus massage is a vagal maneuver used to manage stable narrow complex tachycardia. It is not recommended for unstable patients because it may not be effective quickly enough to stabilize the patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. IV Amiodarone:</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">IV Amiodarone is typically used for stable wide complex tachycardia, especially monomorphic ventricular tachycardia. It is not the first-line treatment for unstable narrow complex tachycardia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In hemodynamically unstable patients with narrow complex tachycardia, synchronized DC cardioversion is the immediate treatment of choice.</span></p>",
      "correct_choice_id": 216497,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11399,
      "choices": [
        {
          "id": 45562,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Cytarabine</span></p>"
        },
        {
          "id": 45563,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Dexamethasone</span></p>"
        },
        {
          "id": 45564,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Doxorubicin</span></p>"
        },
        {
          "id": 45565,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Methotrexate</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"color:black;font-size:12.0pt;\">An 18-year-old girl with the diagnosis of acute promyelocytic leukemia was treated medically. She developed fever and tachypnea and a chest X-ray showed pulmonary infiltrates. What drug should she be given next? (AIIMS MAY 2017)</span></p>",
      "unique_key": "Q1662915",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365396,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. B)&nbsp;Dexamethasone</strong></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\">APML is a leukemia with excellent prognosis managed with Arsenic trioxide and All-Trans retinoic acid. Differentiation syndrome is characterized by <strong>infiltrates, pleural effusion after treatment and improves with Dexamethasone</strong>. Used Intrathecally in children for AML.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Option A</strong>. Cytarabine is used in the treatment of acute myeloid leukemia.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Option C</strong>. Doxorubicin is a cardiotoxic drug used in Hodgkin, CA breast, thyroid.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Option D</strong>. Methotrexate is not recommended in APML treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Dexamethasone is used to manage differentiation syndrome in patients with acute promyelocytic leukemia, characterized by symptoms like fever, tachypnea, and pulmonary infiltrates following treatment with specific leukemia drugs.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Reference -Harrison/Oncology/Acute leukemia/chap100-743</strong></span></p>",
      "correct_choice_id": 45563,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47757,
      "choices": [
        {
          "id": 190635,
          "text": "<p><span style=\"font-size:12.0pt;\">Prednisolone</span></p>"
        },
        {
          "id": 190636,
          "text": "<p><span style=\"font-size:12.0pt;\">Cyclosporin</span></p>"
        },
        {
          "id": 190637,
          "text": "<p><span style=\"font-size:12.0pt;\">Infliximab</span></p>"
        },
        {
          "id": 190638,
          "text": "<p><span style=\"font-size:12.0pt;\">IV Immunoglobulins</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The treatment of choice in acute sarcoidosis is? (NEET PG 2017)</span></p>",
      "unique_key": "Q5183038",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365401,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><strong>Ans. A) Prednisolone.</strong></p><p>&nbsp;</p><p><strong>Explanation:</strong></p><p>&nbsp;</p><p>Corticosteroids are the first-line treatment for sarcoidosis. In the management of sarcoidosis, immunosuppression with corticosteroids (specifically prednisolone) is the established primary therapy. This is particularly important in acute disease presentations where symptom control and prevention of progression are needed.</p><p>&nbsp;</p><p><strong>&nbsp;Other Options:</strong></p><p>&nbsp;</p><p><strong>Option B. Cyclosporin</strong>: While cyclosporine is an immunosuppressive agent, it is not the first-line treatment for acute sarcoidosis. It may be considered in select cases where corticosteroids are contraindicated or ineffective.</p><p>&nbsp;</p><p><strong>Option C. Infliximab</strong>: Infliximab is a TNF-alpha inhibitor that may be used in refractory cases of sarcoidosis, but it is not the first-line treatment for acute sarcoidosis.</p><p>&nbsp;</p><p><strong>Option D. IV Immunoglobulins</strong>: Intravenous immunoglobulins are not indicated as a primary treatment modality for acute sarcoidosis.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">&nbsp;Corticosteroids (prednisolone) remain the first-line treatment for acute sarcoidosis requiring therapy, with alternative immunosuppressive agents considered for steroid-resistant or refractory cases.</span></p>",
      "correct_choice_id": 190635,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "OlderNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11632,
      "choices": [
        {
          "id": 46494,
          "text": "<p><span style=\"font-size:12.0pt;\">Calcium gluconate</span></p>"
        },
        {
          "id": 46495,
          "text": "<p><span style=\"font-size:12.0pt;\">Insulin drip</span></p>"
        },
        {
          "id": 46496,
          "text": "<p><span style=\"font-size:12.0pt;\">Salbutamol nebulisation</span></p>"
        },
        {
          "id": 46497,
          "text": "<p><span style=\"font-size:12.0pt;\">Magnesium sulphate</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Management of hyperkalemia includes all except : (AIIMS NOV 2017)</span></p>",
      "unique_key": "Q7978434",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365449,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Magnesium sulphate</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Magnesium sulfate</strong> is not typically used for the treatment of hyperkalemia. It is more commonly used in the management of eclampsia in pregnant women and for its neuromuscular blocking effects in various other medical conditions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The management of hyperkalemia typically involves interventions that stabilize the cardiac membrane, shift potassium into cells, and remove potassium from the body. Common treatments include:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Calcium gluconate</strong>: Which stabilizes the cardiac membrane and does not lower potassium levels but protects the heart from the effects of hyperkalemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Insulin drip</strong>: Often accompanied by glucose, which drives potassium back into cells, thereby lowering its serum concentration.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp; C. Salbutamol nebulization</strong>: A beta-agonist that promotes the movement of potassium into cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Management of hyperkalemia</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Calcium gluconate- reduces plasma K+ concentration by redistribution in cells rapidly</span></li><li><span style=\"font-size:12.0pt;\">Insulin- lowers plasma K+ concentration by moving potassium intracellular, insulin dose used – 10units of IV regular insulin f/b 50ml of 50%dextrose</span></li><li><span style=\"font-size:12.0pt;\">Salbutamol</span></li><li><span style=\"font-size:12.0pt;\">Cation exchange resins, diuretics, dialysis.</span></li></ul>",
      "correct_choice_id": 46497,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11493,
      "choices": [
        {
          "id": 45938,
          "text": "<p><span style=\"font-size:12.0pt;\">Rituximab</span></p>"
        },
        {
          "id": 45939,
          "text": "<p><span style=\"font-size:12.0pt;\">Cladribine</span></p>"
        },
        {
          "id": 45940,
          "text": "<p><span style=\"font-size:12.0pt;\">Vemurafenib</span></p>"
        },
        {
          "id": 45941,
          "text": "<p><span style=\"font-size:12.0pt;\">Interferon-alpha</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following is the drug of choice for hairy cell leukemia? (AIIMS MAY 2020)</span></p>",
      "unique_key": "Q2807257",
      "question_audio": null,
      "question_video": null,
      "map_id": 33365440,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B)&nbsp;Cladribine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">It is a purine analogue used in the treatment of Hairy cell leukemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Cladribine-phosphates&nbsp;<strong>interfere with DNA synthesis&nbsp;</strong>and repair through incorporation into DNA and through <strong>inhibition of enzymes involved in DNA metabolism</strong>, including DNA polymerase and ribonucleotide reductase.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A&nbsp;&amp;&nbsp;D&nbsp;</strong>are not used in Hairy cell leukemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C</strong>. Hairy cell leukemia patients have mutation in BRAF pathway and hence, <strong>Vemurafenib (BRAF inhibitor) is used as second line agent in refractory cases</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Cladribine remains the first-line treatment for hairy cell leukemia due to its high efficacy in inducing remissions.</span></p>",
      "correct_choice_id": 45939,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}